{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:57:05Z","timestamp":1791421025654,"version":"4.3.3"},"reference-count":664,"publisher":"National Institute for Health and Care Research","issue":"59","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.nationalarchives.gov.uk\/doc\/non-commercial-government-licence\/non-commercial-government-licence.htm"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment programme","doi-asserted-by":"publisher","award":["15\/58\/18"],"award-info":[{"award-number":["15\/58\/18"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journalslibrary.nihr.ac.uk"],"crossmark-restriction":false},"short-container-title":["Health Technol Assess"],"abstract":"\n Background<\/jats:title>\n Cigarette smoking is one of the leading causes of early death. Varenicline [Champix (UK), Pfizer Europe MA EEIG, Brussels, Belgium; or Chantix (USA), Pfizer Inc., Mission, KS, USA], bupropion (Zyban; GlaxoSmithKline, Brentford, UK) and nicotine replacement therapy are licensed aids for quitting smoking in the UK. Although not licensed, e-cigarettes may also be used in English smoking cessation services. Concerns have been raised about the safety of these medicines and e-cigarettes.<\/jats:p>\n <\/jats:sec>\n \n Objectives<\/jats:title>\n To determine the clinical effectiveness, safety and cost-effectiveness of smoking cessation medicines and e-cigarettes.<\/jats:p>\n <\/jats:sec>\n \n Design<\/jats:title>\n Systematic reviews, network meta-analyses and cost-effectiveness analysis informed by the network meta-analysis results.<\/jats:p>\n <\/jats:sec>\n \n Setting<\/jats:title>\n Primary care practices, hospitals, clinics, universities, workplaces, nursing or residential homes.<\/jats:p>\n <\/jats:sec>\n \n Participants<\/jats:title>\n Smokers aged \u2265\u200918 years of all ethnicities using UK-licensed smoking cessation therapies and\/or e-cigarettes.<\/jats:p>\n <\/jats:sec>\n \n Interventions<\/jats:title>\n Varenicline, bupropion and nicotine replacement therapy as monotherapies and in combination treatments at standard, low or high dose, combination nicotine replacement therapy and e-cigarette monotherapies.<\/jats:p>\n <\/jats:sec>\n \n Main outcome measures<\/jats:title>\n Effectiveness \u2013 continuous or sustained abstinence. Safety \u2013 serious adverse events, major adverse cardiovascular events and major adverse neuropsychiatric events.<\/jats:p>\n <\/jats:sec>\n \n Data sources<\/jats:title>\n Ten databases, reference lists of relevant research articles and previous reviews. Searches were performed from inception until 16 March 2017 and updated on 19 February 2019.<\/jats:p>\n <\/jats:sec>\n \n Review methods<\/jats:title>\n Three reviewers screened the search results. Data were extracted and risk of bias was assessed by one reviewer and checked by the other reviewers. Network meta-analyses were conducted for effectiveness and safety outcomes. Cost-effectiveness was evaluated using an amended version of the Benefits of Smoking Cessation on Outcomes model.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Most monotherapies and combination treatments were more effective than placebo at achieving sustained abstinence. Varenicline standard plus nicotine replacement therapy standard (odds ratio 5.75, 95% credible interval 2.27 to 14.90) was ranked first for sustained abstinence, followed by e-cigarette low (odds ratio 3.22, 95% credible interval 0.97 to 12.60), although these estimates have high uncertainty. We found effect modification for counselling and dependence, with a higher proportion of smokers who received counselling achieving sustained abstinence than those who did not receive counselling, and higher odds of sustained abstinence among participants with higher average dependence scores. We found that bupropion standard increased odds of serious adverse events compared with placebo (odds ratio 1.27, 95% credible interval 1.04 to 1.58). There were no differences between interventions in terms of major adverse cardiovascular events. There was evidence of increased odds of major adverse neuropsychiatric events for smokers randomised to varenicline standard compared with those randomised to bupropion standard (odds ratio 1.43, 95% credible interval 1.02 to 2.09). There was a high level of uncertainty about the most cost-effective intervention, although all were cost-effective compared with nicotine replacement therapy low at the \u00a320,000 per quality-adjusted life-year threshold. E-cigarette low appeared to be most cost-effective in the base case, followed by varenicline standard plus nicotine replacement therapy standard. When the impact of major adverse neuropsychiatric events was excluded, varenicline standard plus nicotine replacement therapy standard was most cost-effective, followed by varenicline low plus nicotine replacement therapy standard. When limited to licensed interventions in the UK, nicotine replacement therapy standard was most cost-effective, followed by varenicline standard.<\/jats:p>\n <\/jats:sec>\n \n Limitations<\/jats:title>\n Comparisons between active interventions were informed almost exclusively by indirect evidence. Findings were imprecise because of the small numbers of adverse events identified.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Combined therapies of medicines are among the most clinically effective, safe and cost-effective treatment options for smokers. Although the combined therapy of nicotine replacement therapy and varenicline at standard doses was the most effective treatment, this is currently unlicensed for use in the UK.<\/jats:p>\n <\/jats:sec>\n \n Future work<\/jats:title>\n Researchers should examine the use of these treatments alongside counselling and continue investigating the long-term effectiveness and safety of e-cigarettes for smoking cessation compared with active interventions such as nicotine replacement therapy.<\/jats:p>\n <\/jats:sec>\n \n Study registration<\/jats:title>\n This study is registered as PROSPERO CRD42016041302.<\/jats:p>\n <\/jats:sec>\n \n Funding<\/jats:title>\n \n This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in\n Health Technology Assessment<\/jats:italic>\n ; Vol. 25, No. 59. See the NIHR Journals Library website for further project information.\n <\/jats:p>\n <\/jats:sec>","DOI":"10.3310\/hta25590","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T05:52:45Z","timestamp":1634709165000},"page":"1-224","update-policy":"https:\/\/doi.org\/10.3310\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":155,"title":["Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis"],"prefix":"10.3310","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5418-4034","authenticated-orcid":true,"given":"Kyla H","family":"Thomas","sequence":"first","affiliation":[{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6687-5374","authenticated-orcid":true,"given":"Michael N","family":"Dalili","sequence":"additional","affiliation":[{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9655-3616","authenticated-orcid":true,"given":"Jos\u00e9 A","family":"L\u00f3pez-L\u00f3pez","sequence":"additional","affiliation":[{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4763-8891","authenticated-orcid":true,"given":"Edna","family":"Keeney","sequence":"additional","affiliation":[{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2672-7841","authenticated-orcid":true,"given":"David","family":"Phillippo","sequence":"additional","affiliation":[{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4049-993X","authenticated-orcid":true,"given":"Marcus R","family":"Munaf\u00f2","sequence":"additional","affiliation":[{"name":"Faculty of Life Sciences, School of Psychological Science, University of Bristol, Bristol, UK"},{"name":"MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK"},{"name":"UK Centre for Tobacco and Alcohol Studies, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3099-9877","authenticated-orcid":true,"given":"Matt","family":"Stevenson","sequence":"additional","affiliation":[{"name":"Health Economics and Decision Science, School of Health and Related Research, University of Sheffield, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8014-7480","authenticated-orcid":true,"given":"Deborah M","family":"Caldwell","sequence":"additional","affiliation":[{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2198-3205","authenticated-orcid":true,"given":"Nicky J","family":"Welton","sequence":"additional","affiliation":[{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6221","published-online":{"date-parts":[[2021,10]]},"reference":[{"key":"key20211019135901851_ref1-bib1","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1136\/bmj.321.7257.323","article-title":"Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies","volume":"321","author":"Peto","year":"2000","journal-title":"BMJ"},{"key":"key20211019135901851_ref1-bib2","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1056\/NEJMra1308383","article-title":"Global effects of smoking, of quitting, and of taxing tobacco","volume":"370","author":"Jha","year":"2014","journal-title":"N Engl J Med"},{"key":"key20211019135901851_ref1-bib3","unstructured":"NHS Digital. Statistics on Smoking \u2013 England, 2019. Leeds: NHS Digital; 2019."},{"key":"key20211019135901851_ref1-bib4","unstructured":"Public Health England. Cost of Smoking to the NHS in England: 2015. London: Public Health England; 2017."},{"key":"key20211019135901851_ref1-bib5","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/tc.2008.026294","article-title":"The burden of smoking-related ill health in the UK","volume":"18","author":"Allender","year":"2009","journal-title":"Tob Control"},{"key":"key20211019135901851_ref1-bib6","unstructured":"Action on Smoking and Health (ASH). The Economics of Tobacco. London: ASH; 2017."},{"key":"key20211019135901851_ref1-bib7","unstructured":"National Institute for Health and Care Excellence. Stop Smoking Interventions and Services. NICE guideline 92. London: NICE; 2018."},{"key":"key20211019135901851_ref1-bib8","doi-asserted-by":"publisher","first-page":"3474","DOI":"10.1021\/jm050069n","article-title":"Varenicline: an \u03b14\u03b22 nicotinic receptor partial agonist for smoking cessation","volume":"48","author":"Coe","year":"2005","journal-title":"J Med Chem"},{"key":"key20211019135901851_ref1-bib9","volume-title":"A New Therapy for Smoking Cessation: Varenicline, a Selective Nicotinic Receptor Partial Agonist [SYM10C]","author":"Sands"},{"key":"key20211019135901851_ref1-bib10","volume-title":"Varenicline: Guidance for Health Professionals on a New Prescription-only Stop Smoking Medication","author":"Raw","year":"2006"},{"key":"key20211019135901851_ref1-bib11","unstructured":"National Institute for Health and Care Excellence. Varenicline for Smoking Cessation. London: NICE; 2007."},{"key":"key20211019135901851_ref1-bib12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1177\/2045125316629071","article-title":"Bupropion: a systematic review and meta-analysis of effectiveness as an antidepressant","volume":"6","author":"Patel","year":"2016","journal-title":"Ther Adv Psychopharmacol"},{"key":"key20211019135901851_ref1-bib13","first-page":"88","article-title":"Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine","volume":"288","author":"Fryer","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"key20211019135901851_ref1-bib14","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s00213-003-1445-7","article-title":"Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat","volume":"168","author":"Cryan","year":"2003","journal-title":"Psychopharmacology"},{"key":"key20211019135901851_ref1-bib15","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s00213-007-1041-3","article-title":"Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt","volume":"197","author":"West","year":"2008","journal-title":"Psychopharmacology"},{"key":"key20211019135901851_ref1-bib16","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0376-8716(02)00067-4","article-title":"Mediating mechanisms for the impact of bupropion in smoking cessation treatment","volume":"67","author":"Lerman","year":"2002","journal-title":"Drug Alcohol Depend"},{"key":"key20211019135901851_ref1-bib17","volume-title":"Public Assessment Report. e-Voke 10mg and 15mg Electronic Inhaler (PL 42601\/0003-4) 2015","author":"Medicines and Healthcare products Regulatory Agency"},{"key":"key20211019135901851_ref1-bib18","unstructured":"Action on Smoking and Health (ASH). Briefing: Electronic Cigarettes. London: ASH; 2018."},{"key":"key20211019135901851_ref1-bib19","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1056\/NEJMoa1808779","article-title":"A randomized trial of e-cigarettes versus nicotine-replacement therapy","volume":"380","author":"Hajek","year":"2019","journal-title":"N Engl J Med"},{"key":"key20211019135901851_ref1-bib20","unstructured":"McNeill A, Brose LS, Calder R, Hitchman SC, Hajek P, McRobbie H. E-cigarettes: An Evidence Update \u2013 A Report Commissioned by Public Health England. London: Public Health England; 2015."},{"key":"key20211019135901851_ref1-bib21","unstructured":"McNeill A, Brose LS, Calder R, Bauld L, Robson D. Evidence Review of Ecigarettes and Heated Tobacco Products 2018 \u2013 A Report Commissioned by Public Health England. London: Public Health England; 2018."},{"key":"key20211019135901851_ref1-bib22","unstructured":"Action on Smoking and Health (ASH). Use of E-cigarettes (Vapourisers) Among Adults in Great Britain. London: ASH; 2018."},{"key":"key20211019135901851_ref1-bib23","volume-title":"Prescription Cost Analysis, England, 2013","author":"Prescribing and Primary Care team Health and Social Care Information Centre","year":"2014"},{"key":"key20211019135901851_ref1-bib24","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006103.pub7","article-title":"Nicotine receptor partial agonists for smoking cessation","volume":"5","author":"Cahill","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"key20211019135901851_ref1-bib25","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009329.pub2","article-title":"Pharmacological interventions for smoking cessation: an overview and network meta-analysis","volume":"5","author":"Cahill","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"key20211019135901851_ref1-bib26","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000031.pub4","article-title":"Antidepressants for smoking cessation","volume":"1","author":"Hughes","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"key20211019135901851_ref1-bib27","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000146.pub5","article-title":"Nicotine replacement therapy versus control for smoking cessation","volume":"5","author":"Hartmann-Boyce","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"key20211019135901851_ref1-bib28","first-page":"2","article-title":"Varenicline: adverse psychiatric reactions, including depression","volume":"2","author":"Medicines and Healthcare products Regulatory Agency","year":"2008","journal-title":"Drug Saf Update"},{"key":"key20211019135901851_ref1-bib29","volume-title":"Information for Healthcare Professionals: Varenicline (Marketed as Chantix) and Bupropion (Marketed as Zyban, Wellbutrin and Generics)","author":"US Food and Drug Administration","year":"2009"},{"key":"key20211019135901851_ref1-bib30","unstructured":"US Food and Drug Administration. FDA Drug Safety Communication: FDA Revises Description of Mental Health Side Effects of the Stop-Smoking Medicines Chantix (Varenicline) and Zyban (Bupropion) to Reflect Clinical Trial Findings. US Food and Drug Administration; 2016 (updated 2018). URL: www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-revises-description-mental-health-side-effects-stop-smoking (accessed 8 December 2020)."},{"key":"key20211019135901851_ref1-bib31","volume-title":"Public Health Advisory: FDA Requires New Boxed Warnings for the Smoking Cessation Drugs Chantix and Zyban","author":"US Food and Drug Administration","year":"2009"},{"key":"key20211019135901851_ref1-bib32","doi-asserted-by":"publisher","first-page":"h1168","DOI":"10.1136\/bmj.h1168","article-title":"Mental health effects of varenicline","volume":"350","author":"Harrison-Woolrych","year":"2015","journal-title":"BMJ"},{"key":"key20211019135901851_ref1-bib33","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1016\/S0140-6736(16)30272-0","article-title":"Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial","volume":"387","author":"Anthenelli","year":"2016","journal-title":"Lancet"},{"key":"key20211019135901851_ref1-bib34","unstructured":"European Medicines Agency (EMA). Champix Procedural Steps Taken and Scientific Information after the Authorization. Amsterdam: EMA; 2016. URL: www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Procedural_steps_taken_and_scientific_information_after_authorisation\/human\/000699\/WC500025256.pdf"},{"key":"key20211019135901851_ref1-bib35","volume-title":"FDA Drug Safety Communication: FDA Revises Description of Mental Health Side Effects of the Stop-Smoking Medicines Chantix (Varenicline) and Zyban (Bupropion) to Reflect Clinical Trial Findings","author":"US Food and Drug Administration","year":"2016"},{"key":"key20211019135901851_ref1-bib36","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.biopsych.2006.09.023","article-title":"Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports","volume":"62","author":"Alper","year":"2007","journal-title":"Biol Psychiatry"},{"key":"key20211019135901851_ref1-bib37","doi-asserted-by":"publisher","first-page":"e2856","DOI":"10.1136\/bmj.e2856","article-title":"Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis","volume":"344","author":"Prochaska","year":"2012","journal-title":"BMJ"},{"key":"key20211019135901851_ref1-bib38","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1503\/cmaj.110218","article-title":"Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis","volume":"183","author":"Singh","year":"2011","journal-title":"CMAJ"},{"key":"key20211019135901851_ref1-bib39","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1161\/CIRCULATIONAHA.113.003961","article-title":"Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis","volume":"129","author":"Mills","year":"2014","journal-title":"Circulation"},{"key":"key20211019135901851_ref1-bib40","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1001\/jamainternmed.2018.0397","article-title":"Cardiovascular safety of varenicline, bupropion, and nicotine patch in smokers: a randomized clinical trial","volume":"178","author":"Benowitz","year":"2018","journal-title":"JAMA Intern Med"},{"key":"key20211019135901851_ref1-bib41","unstructured":"BMA Board of Science. E-cigarettes: Balancing Risks and Opportunities British Medical Association; 2018."},{"key":"key20211019135901851_ref1-bib42","unstructured":"Royal College of Physicians. Nicotine Without Smoke: Tobacco Harm Reduction. London: Royal College of Physicians; 2016."},{"key":"key20211019135901851_ref1-bib43","unstructured":"WHO Framework Convention on Tobacco Control. Electronic Nicotine Delivery Systems and Electronic Non-Nicotine Delivery Systems (ENDS\/ENNDS). Geneva: World Health Organization; 2016."},{"key":"key20211019135901851_ref1-bib44","volume-title":"Outbreak of Lung Injury Associated with E-Cigarette Use, or Vaping","author":"Centers for Disease Control and Prevention","year":"2019"},{"key":"key20211019135901851_ref1-bib45","volume-title":"Country Laws Regulation E-cigarettes: A Policy Scan","author":"Global Tobacco Control","year":"2019"},{"key":"key20211019135901851_ref1-bib46","volume-title":"Foreign Travel Advice \u2013 Thailand","author":"UK Government","year":"2019"},{"key":"key20211019135901851_ref1-bib47","doi-asserted-by":"publisher","first-page":"e27016","DOI":"10.1371\/journal.pone.0027016","article-title":"Suicidal behavior and depression in smoking cessation treatments","volume":"6","author":"Moore","year":"2011","journal-title":"PLOS ONE"},{"key":"key20211019135901851_ref1-bib48","doi-asserted-by":"publisher","first-page":"763","DOI":"10.2165\/11594450-000000000-00000","article-title":"Psychiatric adverse events associated with varenicline: an intensive postmarketing prospective cohort study in New Zealand","volume":"34","author":"Harrison-Woolrych","year":"2011","journal-title":"Drug Saf"},{"key":"key20211019135901851_ref1-bib49","doi-asserted-by":"publisher","first-page":"499","DOI":"10.2165\/00002018-200932060-00006","article-title":"Safety and drug utilization profile of varenicline as used in general practice in England: interim results from a prescription-event monitoring study","volume":"32","author":"Kasliwal","year":"2009","journal-title":"Drug Saf"},{"key":"key20211019135901851_ref1-bib50","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2165\/11319180-000000000-00000","article-title":"Psychiatric adverse events in randomized, double-blind, placebo-controlled clinical trials of varenicline: a pooled analysis","volume":"33","author":"Tonstad","year":"2010","journal-title":"Drug Saf"},{"key":"key20211019135901851_ref1-bib51","doi-asserted-by":"publisher","first-page":"h1109","DOI":"10.1136\/bmj.h1109","article-title":"Risk of neuropsychiatric adverse events associated with varenicline: systematic review and meta-analysis","volume":"350","author":"Thomas","year":"2015","journal-title":"BMJ"},{"key":"key20211019135901851_ref1-bib52","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1176\/appi.ajp.2013.12121599","article-title":"Varenicline, smoking cessation, and neuropsychiatric adverse events","volume":"170","author":"Gibbons","year":"2013","journal-title":"Am J Psychiatry"},{"key":"key20211019135901851_ref1-bib53","doi-asserted-by":"publisher","first-page":"f5704","DOI":"10.1136\/bmj.f5704","article-title":"Smoking cessation treatment and risk of depression, suicide, and self harm in the Clinical Practice Research Datalink: prospective cohort study","volume":"347","author":"Thomas","year":"2013","journal-title":"BMJ"},{"key":"key20211019135901851_ref1-bib54","doi-asserted-by":"publisher","first-page":"b3805","DOI":"10.1136\/bmj.b3805","article-title":"Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database","volume":"339","author":"Gunnell","year":"2009","journal-title":"BMJ"},{"key":"key20211019135901851_ref1-bib55","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/j.1360-0443.2012.04024.x","article-title":"Neuropsychiatric events in varenicline and nicotine replacement patch users in the Military Health System","volume":"108","author":"Meyer","year":"2013","journal-title":"Addiction"},{"key":"key20211019135901851_ref1-bib56","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.2146\/ajhp100196","article-title":"Mental health stability in veterans with posttraumatic stress disorder receiving varenicline","volume":"67","author":"Campbell","year":"2010","journal-title":"Am J Health Syst Pharm"},{"key":"key20211019135901851_ref1-bib57","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S2213-2600(15)00320-3","article-title":"Cardiovascular and neuropsychiatric risks of varenicline: a retrospective cohort study","volume":"3","author":"Kotz","year":"2015","journal-title":"Lancet Respir Med"},{"issue":"33","key":"key20211019135901851_ref1-bib58","doi-asserted-by":"publisher","DOI":"10.3310\/hta18330","article-title":"What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation","volume":"18","author":"Leaviss","year":"2014","journal-title":"Health Technol Assess"},{"key":"key20211019135901851_ref1-bib59","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/9781118344828.ch05","volume-title":"Textbook of Pharmacoepidemiology","author":"Strom","year":"2013","edition":"2nd"},{"key":"key20211019135901851_ref1-bib60","unstructured":"Canadian Collaboration for Drug Safety, Effectiveness and Network Meta-Analysis. A Systematic Review and Network Meta-Analysis of Pharmacologic Interventions for Smoking Cessation. Ottawa, ON: Canadian Collaboration for Drug Safety, Effectiveness and Network Meta-Analysis; 2014."},{"key":"key20211019135901851_ref1-bib61","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/add.14829","article-title":"Cost-effectiveness of e-cigarettes compared with nicotine replacement therapy in stop smoking services in England (TEC study): a randomized controlled trial","volume":"115","author":"Li","year":"2020","journal-title":"Addiction"},{"key":"key20211019135901851_ref1-bib62","unstructured":"Centre for Reviews and Dissemination. Systematic Reviews: CRD\u2019s Guidance for Undertaking Reviews in Health Care. 3rd edn. York: Centre for Reviews and Dissemination; 2009."},{"key":"key20211019135901851_ref1-bib63","doi-asserted-by":"crossref","DOI":"10.1002\/9780470712184","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2008"},{"key":"key20211019135901851_ref1-bib64","doi-asserted-by":"publisher","first-page":"e015414","DOI":"10.1136\/bmjopen-2016-015414","article-title":"How do smoking cessation medicines compare with respect to their neuropsychiatric safety? A protocol for a systematic review, network meta-analysis and cost-effectiveness analysis","volume":"7","author":"Thomas","year":"2017","journal-title":"BMJ Open"},{"key":"key20211019135901851_ref1-bib65","volume-title":"British National Formulary (BNF)","author":"National Institute for Health and Care Excellence","year":"2016"},{"key":"key20211019135901851_ref1-bib66","unstructured":"Medicines and Healthcare products Regulatory Agency. Public Assessment Report. e-Voke 10mg and 15mg Electronic Inhaler (PL 42601\/0003-4). Secondary Public Assessment Report. e-Voke 10mg and 15mg Electronic Inhaler (PL 42601\/0003-4). 2015."},{"key":"key20211019135901851_ref1-bib67","doi-asserted-by":"publisher","DOI":"10.1111\/add.15675","article-title":"Comparative clinical effectiveness and safety of tobacco cessation pharmacotherapies and electronic cigarettes: a systematic review and network meta-analysis of randomized controlled trials [published online ahead of print 11 October 2021]","author":"Thomas","year":"2021","journal-title":"Addiction"},{"key":"key20211019135901851_ref1-bib68","volume-title":"Glossary","author":"Cochrane Tobacco Addiction Group"},{"key":"key20211019135901851_ref1-bib69","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.clinthera.2007.06.012","article-title":"Efficacy and tolerability of varenicline, an \u03b14\u03b22 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers","volume":"29","author":"Nakamura","year":"2007","journal-title":"Clin Ther"},{"key":"key20211019135901851_ref1-bib70","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1097\/00004714-200102000-00017","article-title":"A preliminary study of bupropion sustained-release for smoking cessation in patients with chronic posttraumatic stress disorder","volume":"21","author":"Hertzberg","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"key20211019135901851_ref1-bib71","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000146.pub4","article-title":"Nicotine replacement therapy for smoking cessation","volume":"11","author":"Stead","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"key20211019135901851_ref1-bib72","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010216.pub3","article-title":"Electronic cigarettes for smoking cessation","volume":"9","author":"Hartmann-Boyce","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"key20211019135901851_ref1-bib73","volume-title":"Covidence Systematic Review Software","author":"Veritas Health Innovation"},{"key":"key20211019135901851_ref1-bib74","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"key20211019135901851_ref1-bib75","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1002\/sim.1875","article-title":"Combination of direct and indirect evidence in mixed treatment comparisons","volume":"23","author":"Lu","year":"2004","journal-title":"Stat Med"},{"key":"key20211019135901851_ref1-bib76","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1136\/bmj.331.7521.897","article-title":"Simultaneous comparison of multiple treatments: combining direct and indirect evidence","volume":"331","author":"Caldwell","year":"2005","journal-title":"BMJ"},{"key":"key20211019135901851_ref1-bib77","doi-asserted-by":"crossref","DOI":"10.1002\/9781118951651","volume-title":"Network Meta-analysis for Decision-making","author":"Dias","year":"2018"},{"key":"key20211019135901851_ref1-bib78","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1002\/sim.1761","article-title":"What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data","volume":"23","author":"Sweeting","year":"2004","journal-title":"Stat Med"},{"key":"key20211019135901851_ref1-bib79","doi-asserted-by":"publisher","first-page":"h1551","DOI":"10.1136\/bmj.h1551","article-title":"Impact of smoking and smoking cessation on cardiovascular events and mortality among older adults: meta-analysis of individual participant data from prospective cohort studies of the CHANCES consortium","volume":"350","author":"Mons","year":"2015","journal-title":"BMJ"},{"key":"key20211019135901851_ref1-bib80","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1177\/0272989X12458724","article-title":"Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials","volume":"33","author":"Dias","year":"2013","journal-title":"Med Decis Making"},{"key":"key20211019135901851_ref1-bib81","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/1467-9868.00353","article-title":"Bayesian measures of model complexity and fit","volume":"64","author":"Spiegelhalter","year":"2002","journal-title":"J R Stat Soc B"},{"key":"key20211019135901851_ref1-bib82","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/sim.3767","article-title":"Checking consistency in mixed treatment comparison meta-analysis","volume":"29","author":"Dias","year":"2010","journal-title":"Stat Med"},{"key":"key20211019135901851_ref1-bib83","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1177\/0962280207080643","article-title":"Evaluation of networks of randomized trials","volume":"17","author":"Salanti","year":"2008","journal-title":"Stat Methods Med Res"},{"key":"key20211019135901851_ref1-bib84","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1136\/bmj.326.7387.472","article-title":"Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses","volume":"326","author":"Song","year":"2003","journal-title":"BMJ"},{"key":"key20211019135901851_ref1-bib85","volume-title":"NICE DSU Technical Support Document 4: Inconsistency in Networks of Evidence Based on Randomised Controlled Trials","author":"Dias","year":"2011"},{"key":"key20211019135901851_ref1-bib86","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/sim.4780140406","article-title":"A random-effects regression model for meta-analysis","volume":"14","author":"Berkey","year":"1995","journal-title":"Stat Med"},{"key":"key20211019135901851_ref1-bib87","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1111\/j.1360-0443.1991.tb01879.x","article-title":"The Fagerstr\u00f6m Test for Nicotine Dependence: a revision of the Fagerstr\u00f6m Tolerance Questionnaire","volume":"86","author":"Heatherton","year":"1991","journal-title":"Br J Addict"},{"key":"key20211019135901851_ref1-bib88","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/0306-4603(78)90024-2","article-title":"Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment","volume":"3","author":"Fagerstr\u00f6m","year":"1978","journal-title":"Addict Behav"},{"key":"key20211019135901851_ref1-bib89","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/j.1360-0443.1989.tb03059.x","article-title":"Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day","volume":"84","author":"Heatherton","year":"1989","journal-title":"Br J Addict"},{"key":"key20211019135901851_ref1-bib90","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"key20211019135901851_ref1-bib91","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/rssa.12341","article-title":"Sensitivity of treatment recommendations to bias in network meta-analysis","volume":"181","author":"Phillippo","year":"2018","journal-title":"J R Stat Soc Ser A Stat Soc"},{"key":"key20211019135901851_ref1-bib92","doi-asserted-by":"publisher","first-page":"538","DOI":"10.7326\/M18-3542","article-title":"Threshold analysis as an alternative to GRADE for assessing confidence in guideline recommendations based on network meta-analyses threshold analysis in guideline development","volume":"170","author":"Phillippo","year":"2019","journal-title":"Ann Intern Med"},{"key":"key20211019135901851_ref1-bib93","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jclinepi.2016.07.003","article-title":"A threshold analysis assessed the credibility of conclusions from network meta-analysis","volume":"80","author":"Caldwell","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"key20211019135901851_ref1-bib94","unstructured":"National Institute for Health and Care Excellence (NICE). Guide to the Methods of Technology Appraisal. London: NICE; 2013."},{"key":"key20211019135901851_ref1-bib95","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1136\/tc.10.1.55","article-title":"Development of the health and economic consequences of smoking interactive model","volume":"10","author":"Orme","year":"2001","journal-title":"Tob Control"},{"key":"key20211019135901851_ref1-bib96","doi-asserted-by":"publisher","first-page":"655","DOI":"10.2165\/11317730-000000000-00000","article-title":"Cost effectiveness of varenicline in Belgium, compared with bupropion, nicotine replacement therapy, brief counselling and unaided smoking cessation: a BENESCO Markov cost-effectiveness analysis","volume":"29","author":"Annemans","year":"2009","journal-title":"Clin Drug Investig"},{"key":"key20211019135901851_ref1-bib97","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1185\/030079908x242917","article-title":"Cost-effectiveness of varenicline compared with bupropion, NRT, and nortriptyline for smoking cessation in the Netherlands","volume":"24","author":"Hoogendoorn","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"key20211019135901851_ref1-bib98","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1185\/03007990903542666","article-title":"Cost effectiveness of varenicline versus bupropion and unaided cessation for smoking cessation in a cohort of Finnish adult smokers","volume":"26","author":"Linden","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"key20211019135901851_ref1-bib99","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/j.1524-4733.2009.00631.x","article-title":"Evaluation of cost-utility of varenicline compared with existing smoking cessation therapies in South Korea","volume":"12","author":"Bae","year":"2009","journal-title":"Value Health"},{"key":"key20211019135901851_ref1-bib100","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/j.1365-2753.2008.01045.x","article-title":"Smoking-cessation therapy using varenicline: the cost-utility of an additional 12-week course of varenicline for the maintenance of smoking abstinence","volume":"15","author":"Bolin","year":"2009","journal-title":"J Eval Clin Pract"},{"key":"key20211019135901851_ref1-bib101","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1093\/eurpub\/ckp075","article-title":"Cost-effectiveness of varenicline compared with nicotine patches for smoking cessation \u2013 results from four European countries","volume":"19","author":"Bolin","year":"2009","journal-title":"Eur J Public Health"},{"key":"key20211019135901851_ref1-bib102","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.rmed.2007.12.018","article-title":"Varenicline as compared to bupropion in smoking-cessation therapy \u2013 cost-utility results for Sweden 2003","volume":"102","author":"Bolin","year":"2008","journal-title":"Respir Med"},{"key":"key20211019135901851_ref1-bib103","doi-asserted-by":"publisher","first-page":"497","DOI":"10.2165\/00019053-200826060-00004","article-title":"Cost-utility analysis of varenicline versus existing smoking cessation strategies using the BENESCO simulation model: application to a population of US adult smokers","volume":"26","author":"Howard","year":"2008","journal-title":"PharmacoEconomics"},{"key":"key20211019135901851_ref1-bib104","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1524-4733.2009.00672.x","article-title":"The cost-effectiveness of an extended course (12+12 weeks) of varenicline compared with other available smoking cessation strategies in the United States: an extension and update to the BENESCO model","volume":"13","author":"Knight","year":"2010","journal-title":"Value Health"},{"key":"key20211019135901851_ref1-bib105","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/j.1524-4733.2009.00612.x","article-title":"Crossing borders: factors affecting differences in cost-effectiveness of smoking cessation interventions between European countries","volume":"13","author":"Vemer","year":"2010","journal-title":"Value Health"},{"key":"key20211019135901851_ref1-bib106","unstructured":"ONS. Population Estimates for UK, England and Wales, Scotland and Northern Ireland, Mid-2016. Newport: ONS; 2017."},{"key":"key20211019135901851_ref1-bib107","unstructured":"ONS. Deaths by Single Year of Age, UK, 2016. Newport: ONS; 2016."},{"key":"key20211019135901851_ref1-bib108","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1093\/ntr\/ntv079","article-title":"Relapse-prevention booklets as an adjunct to a tobacco quitline: a randomized controlled effectiveness trial","volume":"18","author":"Unrod","year":"2016","journal-title":"Nicotine Tob Res"},{"key":"key20211019135901851_ref1-bib109","volume-title":"Chronic Obstructive Pulmonary Disease Statistics","author":"British Lung Foundation"},{"key":"key20211019135901851_ref1-bib110","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1136\/thorax.55.9.789","article-title":"Recent trends in physician diagnosed COPD in women and men in the UK","volume":"55","author":"Soriano","year":"2000","journal-title":"Thorax"},{"key":"key20211019135901851_ref1-bib111","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/sj.bjc.6605148","article-title":"Cancer prevalence in the United Kingdom: estimates for 2008","volume":"101","author":"Maddams","year":"2009","journal-title":"Br J Cancer"},{"key":"key20211019135901851_ref1-bib112","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1093\/annonc\/mdg169","article-title":"Cancer prevalence in the UK: results from the EUROPREVAL study","volume":"14","author":"Forman","year":"2003","journal-title":"Ann Oncol"},{"key":"key20211019135901851_ref1-bib113","unstructured":"NHS Digital. Health Survey for England, 2016. Adult Health Trends. Leeds: NHS Digital; 2016."},{"key":"key20211019135901851_ref1-bib114","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1136\/heartjnl-2015-307516","article-title":"The epidemiology of cardiovascular disease in the UK 2014","volume":"101","author":"Bhatnagar","year":"2015","journal-title":"Heart"},{"key":"key20211019135901851_ref1-bib115","unstructured":"NHS Digital. Statistics on Smoking, England \u2013 2017. Leeds: NHS Digital; 2017."},{"key":"key20211019135901851_ref1-bib116","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1164\/ajrccm.159.6.9809042","article-title":"Cigarette smoking and ozone-associated emergency department use for asthma by adults in New York City","volume":"159","author":"Cassino","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"key20211019135901851_ref1-bib117","unstructured":"Pfizer Ltd. Manufacturer\u2019s Submission for NICE STA of Varenicline for Smoking Cessation. Tadworth: Pfizer Ltd; 2007."},{"key":"key20211019135901851_ref1-bib118","volume-title":"Cancer Registration Statistics, England: 2016, 2018","author":"King","year":"2018"},{"key":"key20211019135901851_ref1-bib119","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1093\/aje\/kwj340","article-title":"High cumulative risk of lung cancer death among smokers and nonsmokers in Central and Eastern Europe","volume":"164","author":"Brennan","year":"2006","journal-title":"Am J Epidemiol"},{"key":"key20211019135901851_ref1-bib120","unstructured":"British Heart Foundation. CVD Statistics Compendium. London: British Heart Foundation; 2018."},{"key":"key20211019135901851_ref1-bib121","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1093\/ntr\/ntq175","article-title":"Long-term smoking relapse: a study using the British Household Panel Survey","volume":"12","author":"Hawkins","year":"2010","journal-title":"Nicotine Tob Res"},{"key":"key20211019135901851_ref1-bib122","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/14622200110098428","article-title":"Smoking relapse after 2 years of abstinence: findings from the VA Normative Aging Study","volume":"4","author":"Krall","year":"2002","journal-title":"Nicotine Tob Res"},{"key":"key20211019135901851_ref1-bib123","unstructured":"Health Information and Quality Authority (HIQA). Health Technology Assessment (HTA) of Smoking Cessation Interventions. Dublin: HIQA; 2017."},{"key":"key20211019135901851_ref1-bib124","volume-title":"European Cardiovascular Disease Statistics 2012","author":"Nichols","year":"2012"},{"key":"key20211019135901851_ref1-bib125","unstructured":"HM Revenue & Customs. February 2019: Monthly Exchange Rates. London: HM Revenue & Customs; 2019."},{"key":"key20211019135901851_ref1-bib126","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0954-6111(03)80027-6","article-title":"The burden of COPD in the U.K.: results from the Confronting COPD survey","volume":"97","author":"Britton","year":"2003","journal-title":"Respir Med"},{"key":"key20211019135901851_ref1-bib127","volume-title":"Cost-effectiveness of Interventions for Smoking Cessation","author":"Flack","year":"2007"},{"key":"key20211019135901851_ref1-bib128","unstructured":"British Heart Foundation. Cardiovascular Disease Statistics 2014. London: British Heart Foundation; 2014."},{"key":"key20211019135901851_ref1-bib129","first-page":"99","article-title":"Rhodes G","volume":"6","author":"McMurray","year":"1993","journal-title":"An evaluation of the cost of heart failure to the National Health Service in the UKJ Med Econ"},{"key":"key20211019135901851_ref1-bib130","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1177\/2396987317746516","article-title":"The economic burden of stroke care in England, Wales and Northern Ireland: using a national stroke register to estimate and report patient-level health economic outcomes in stroke","volume":"3","author":"Xu","year":"2018","journal-title":"Eur Stroke J"},{"issue":"36","key":"key20211019135901851_ref1-bib131","doi-asserted-by":"publisher","DOI":"10.3310\/hta17360","article-title":"Echocardiography in newly diagnosed atrial fibrillation patients: a systematic review and economic evaluation","volume":"17","author":"Simpson","year":"2013","journal-title":"Health Technol Assess"},{"key":"key20211019135901851_ref1-bib132","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1183\/13993003.00188-2015","article-title":"Trends and predictors of asthma costs: results from a 10-year longitudinal study","volume":"47","author":"Tan","year":"2016","journal-title":"Eur Respir J"},{"key":"key20211019135901851_ref1-bib133","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/thorax.55.1.19","article-title":"Risk factors and costs associated with an asthma attack","volume":"55","author":"Hoskins","year":"2000","journal-title":"Thorax"},{"key":"key20211019135901851_ref1-bib134","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1017\/S0033291713002067","article-title":"Modelling the cost-effectiveness of preventing major depression in general practice patients","volume":"44","author":"Hunter","year":"2014","journal-title":"Psychol Med"},{"key":"key20211019135901851_ref1-bib135","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S2215-0366(17)30367-X","article-title":"General hospital costs in England of medical and psychiatric care for patients who self-harm: a retrospective analysis","volume":"4","author":"Tsiachristas","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"key20211019135901851_ref1-bib136","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198526629.001.0001","volume-title":"Decision Modelling for Health Economic Evaluation","author":"Briggs","year":"2006"},{"key":"key20211019135901851_ref1-bib137","volume-title":"British National Formulary","author":"Joint Formulary Committee","year":"2018"},{"key":"key20211019135901851_ref1-bib138","doi-asserted-by":"publisher","first-page":"j5543","DOI":"10.1136\/bmj.j5543","article-title":"Electronic cigarettes for smoking cessation","volume":"360","author":"Hartmann-Boyce","year":"2018","journal-title":"BMJ"},{"key":"key20211019135901851_ref1-bib139","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1136\/tobaccocontrol-2015-052874","article-title":"Combustible cigarettes cost less to use than e-cigarettes: global evidence and tax policy implications","volume":"26","author":"Liber","year":"2017","journal-title":"Tob Control"},{"key":"key20211019135901851_ref1-bib140","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/j.1524-4733.2010.00700.x","article-title":"Populating an economic model with health state utility values: moving toward better practice","volume":"13","author":"Ara","year":"2010","journal-title":"Value Health"},{"key":"key20211019135901851_ref1-bib141","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1097\/JTO.0b013e3181f77a6a","article-title":"Derivation of utility values from European Organization for Research and Treatment of Cancer Quality of Life-Core 30 questionnaire values in lung cancer","volume":"5","author":"Jang","year":"2010","journal-title":"J Thorac Oncol"},{"key":"key20211019135901851_ref1-bib142","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1080\/13696998.2017.1377718","article-title":"Cost-effectiveness of osimertinib in the UK for advanced EGFR-T790M non-small cell lung cancer","volume":"21","author":"Bertranou","year":"2018","journal-title":"J Med Econ"},{"key":"key20211019135901851_ref1-bib143","doi-asserted-by":"publisher","first-page":"855","DOI":"10.2165\/00019053-200119080-00007","article-title":"Quality of life and utility in patients with non-small cell lung cancer. Quality-of-life Study Group of the Master 2 Project in Pharmacoeconomics","volume":"19","author":"Trippoli","year":"2001","journal-title":"PharmacoEconomics"},{"key":"key20211019135901851_ref1-bib144","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.rmed.2007.11.016","article-title":"Use of a preference-based measure of health (EQ-5D) in COPD and asthma","volume":"102","author":"Pickard","year":"2008","journal-title":"Respir Med"},{"key":"key20211019135901851_ref1-bib145","doi-asserted-by":"publisher","first-page":"619","DOI":"10.2165\/00019053-200523060-00008","article-title":"Development of an economic model to assess the cost effectiveness of treatment interventions for chronic obstructive pulmonary disease","volume":"23","author":"Spencer","year":"2005","journal-title":"PharmacoEconomics"},{"key":"key20211019135901851_ref1-bib146","doi-asserted-by":"publisher","first-page":"e0152030","DOI":"10.1371\/journal.pone.0152030","article-title":"Multivariate meta-analysis of preference-based quality of life values in coronary heart disease","volume":"11","author":"Stevanovi\u0107","year":"2016","journal-title":"PLOS ONE"},{"key":"key20211019135901851_ref1-bib147","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2165\/00019053-200523020-00005","article-title":"Cost effectiveness of treating low HDL-cholesterol in the primary prevention of coronary heart disease","volume":"23","author":"Hay","year":"2005","journal-title":"PharmacoEconomics"},{"key":"key20211019135901851_ref1-bib148","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1161\/01.STR.0000196990.69412.fb","article-title":"Long-term outcome after stroke: evaluating health-related quality of life using utility measurements","volume":"37","author":"Haacke","year":"2006","journal-title":"Stroke"},{"key":"key20211019135901851_ref1-bib149","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2165\/00019053-200321030-00004","article-title":"A meta-analysis of quality-of-life estimates for stroke","volume":"21","author":"Tengs","year":"2003","journal-title":"PharmacoEconomics"},{"key":"key20211019135901851_ref1-bib150","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1161\/01.str.29.6.1083","article-title":"Cost-effectiveness of preference-based antithrombotic therapy for patients with nonvalvular atrial fibrillation","volume":"29","author":"Gage","year":"1998","journal-title":"Stroke"},{"key":"key20211019135901851_ref1-bib151","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3132\/pcrj.2007.00002","article-title":"The impact of asthma exacerbations on health-related quality of life in moderate to severe asthma patients in the UK","volume":"16","author":"Lloyd","year":"2007","journal-title":"Prim Care Respir J"},{"key":"key20211019135901851_ref1-bib152","doi-asserted-by":"publisher","first-page":"537","DOI":"10.2165\/00019053-200422080-00005","article-title":"Psychometric and utility-based measures of health status of asthmatic patients with different disease control level","volume":"22","author":"Szende","year":"2004","journal-title":"PharmacoEconomics"},{"issue":"16","key":"key20211019135901851_ref1-bib153","doi-asserted-by":"publisher","DOI":"10.3310\/hta9160","article-title":"A randomised controlled trial to compare the cost-effectiveness of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine","volume":"9","author":"Peveler","year":"2005","journal-title":"Health Technol Assess"},{"key":"key20211019135901851_ref1-bib154","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1192\/bjp.188.4.337","article-title":"Cost-effectiveness and cost-utility of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine: randomised controlled trial","volume":"188","author":"Kendrick","year":"2006","journal-title":"Br J Psychiatry"},{"key":"key20211019135901851_ref1-bib155","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s00127-008-0463-5","article-title":"Putting the \u2018Q\u2019 in depression QALYs: a comparison of utility measurement using EQ-5D and SF-6D health related quality of life measures","volume":"44","author":"Mann","year":"2009","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"key20211019135901851_ref1-bib156","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1192\/bjp.bp.109.073080","article-title":"Cost-effectiveness of therapist-delivered online cognitive-behavioural therapy for depression: randomised controlled trial","volume":"197","author":"Hollinghurst","year":"2010","journal-title":"Br J Psychiatry"},{"key":"key20211019135901851_ref1-bib157","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1017\/s0033291703008183","article-title":"Cost-effectiveness of brief cognitive behaviour therapy versus treatment as usual in recurrent deliberate self-harm: a decision-making approach","volume":"33","author":"Byford","year":"2003","journal-title":"Psychol Med"},{"key":"key20211019135901851_ref1-bib158","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1093\/ije\/dyx109","article-title":"The effectiveness of varenicline versus nicotine replacement therapy on long-term smoking cessation in primary care: a prospective cohort study of electronic medical records","volume":"46","author":"Taylor","year":"2017","journal-title":"Int J Epidemiol"},{"key":"key20211019135901851_ref1-bib159","unstructured":"York Health Economics Consortium. Net Monetary Benefit. York: York Health Economics Consortium; 2016. URL: https:\/\/yhec.co.uk\/glossary\/net-monetary-benefit\/ (accessed September 2019)."},{"key":"key20211019135901851_ref1-bib160","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/(SICI)1099-1050(199611)5:6<513::AID-HEC237>3.0.CO;2-9","article-title":"An economic approach to clinical trial design and research priority-setting","volume":"5","author":"Claxton","year":"1996","journal-title":"Health Econ"},{"key":"key20211019135901851_ref1-bib161","unstructured":"University of Sheffield. Sheffield Accelerated Value of Information. Release version 2.0.8. Sheffield: University of Sheffield; 2015."},{"key":"key20211019135901851_ref1-bib162","volume-title":"Gaussian Processes for Machine Learning","author":"Rasmussen","year":"2006"},{"key":"key20211019135901851_ref1-bib163","doi-asserted-by":"publisher","first-page":"961751","DOI":"10.1155\/2013\/961751","article-title":"A randomized controlled trial of two different lengths of nicotine replacement therapy for smoking cessation","volume":"2013","author":"Abdullah","year":"2013","journal-title":"Biomed Res Int"},{"key":"key20211019135901851_ref1-bib164","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0140-6736(89)91671-1","article-title":"Controlled trial of transdermal nicotine patch in tobacco withdrawal","volume":"1","author":"Abelin","year":"1989","journal-title":"Lancet"},{"key":"key20211019135901851_ref1-bib165","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1001\/jama.288.4.468","article-title":"Sustained-release bupropion for smoking cessation in African Americans: a randomized controlled trial","volume":"288","author":"Ahluwalia","year":"2002","journal-title":"JAMA"},{"key":"key20211019135901851_ref1-bib166","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1525-1497.1998.00001.x","article-title":"Smoking cessation among inner-city African Americans using the nicotine transdermal patch","volume":"13","author":"Ahluwalia","year":"1998","journal-title":"J Gen Intern Med"},{"key":"key20211019135901851_ref1-bib167","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/j.1360-0443.2006.01461.x","article-title":"The effects of nicotine gum and counseling among African American light smokers: a 2\u2009\u00d7\u20092 factorial design","volume":"101","author":"Ahluwalia","year":"2006","journal-title":"Addiction"},{"key":"key20211019135901851_ref1-bib168","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.amepre.2018.07.015","article-title":"Incentives and patches for Medicaid smokers: an RCT","volume":"55","author":"Anderson","year":"2018","journal-title":"Am J Prev Med"},{"key":"key20211019135901851_ref1-bib169","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ypmed.2016.07.008","article-title":"Effect of a smoking cessation intervention for women in subsidized neighborhoods: a randomized controlled trial","volume":"90","author":"Andrews","year":"2016","journal-title":"Prev Med"},{"key":"key20211019135901851_ref1-bib170","doi-asserted-by":"publisher","first-page":"390","DOI":"10.7326\/0003-4819-159-6-201309170-00005","article-title":"Effects of varenicline on smoking cessation in adults with stably treated current or past major depression: a randomized trial","volume":"159","author":"Anthenelli","year":"2013","journal-title":"Ann Intern Med"},{"key":"key20211019135901851_ref1-bib171","first-page":"183","article-title":"Smoking cessation through the use of nicotine chewing gum: a double-blind trial in Thailand","volume":"10","author":"Areechon","year":"1988","journal-title":"Clin Ther"},{"key":"key20211019135901851_ref1-bib172","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1186\/s12879-016-1727-4","article-title":"A randomized controlled trial of smoking cessation methods in patients newly-diagnosed with pulmonary tuberculosis","volume":"16","author":"Aryanpur","year":"2016","journal-title":"BMC Infect Dis"},{"key":"key20211019135901851_ref1-bib173","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1136\/thx.2007.090647","article-title":"Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial","volume":"63","author":"Aubin","year":"2008","journal-title":"Thorax"},{"key":"key20211019135901851_ref1-bib174","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1111\/j.1360-0443.2004.00814.x","article-title":"Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial","volume":"99","author":"Aubin","year":"2004","journal-title":"Addiction"},{"key":"key20211019135901851_ref1-bib175","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1176\/ajp.2006.163.11.1934","article-title":"A randomized controlled trial of a smoking cessation intervention among people with a psychotic disorder","volume":"163","author":"Baker","year":"2006","journal-title":"Am J Psychiatry"},{"key":"key20211019135901851_ref1-bib176","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1001\/jama.2015.19284","article-title":"Effects of nicotine patch vs varenicline vs combination nicotine replacement therapy on smoking cessation at 26 weeks: a randomized clinical trial","volume":"315","author":"Baker","year":"2016","journal-title":"JAMA"},{"key":"key20211019135901851_ref1-bib177","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.addbeh.2017.11.033","article-title":"Electronic cigarettes for adults with tobacco dependence enrolled in a tobacco treatment program: a pilot study","volume":"80","author":"Baldassarri","year":"2018","journal-title":"Addict Behav"},{"key":"key20211019135901851_ref1-bib178","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.clpt.2005.08.019","article-title":"Smoking reduction treatment with 4-mg nicotine gum: a double-blind, randomized, placebo-controlled study","volume":"78","author":"Batra","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"key20211019135901851_ref1-bib179","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.annemergmed.2015.03.030","article-title":"Successful tobacco dependence treatment in low-income emergency department patients: a randomized trial","volume":"66","author":"Bernstein","year":"2015","journal-title":"Ann Emerg Med"},{"key":"key20211019135901851_ref1-bib180","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1472-6831-7-5","article-title":"A randomised controlled trial of a smoking cessation intervention delivered by dental hygienists: a feasibility study","volume":"7","author":"Binnie","year":"2007","journal-title":"BMC Oral Health"},{"key":"key20211019135901851_ref1-bib181","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1016\/j.juro.2012.11.075","article-title":"Brief smoking cessation intervention: a prospective trial in the urology setting","volume":"189","author":"Bjurlin","year":"2013","journal-title":"J Urol"},{"key":"key20211019135901851_ref1-bib182","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1001\/archinte.1989.00390080080018","article-title":"Controlled trial of nicotine polacrilex gum with supportive measures","volume":"149","author":"Bl\u00f6ndal","year":"1989","journal-title":"Arch Intern Med"},{"key":"key20211019135901851_ref1-bib183","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1183\/09031936.97.10071585","article-title":"A double-blind randomized trial of nicotine nasal spray as an aid in smoking cessation","volume":"10","author":"Bl\u00f6ndal","year":"1997","journal-title":"Eur Respir J"},{"key":"key20211019135901851_ref1-bib184","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1136\/bmj.318.7179.285","article-title":"Nicotine nasal spray with nicotine patch for smoking cessation: randomised trial with six year follow up","volume":"318","author":"Blondal","year":"1999","journal-title":"BMJ"},{"key":"key20211019135901851_ref1-bib185","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1001\/archinte.160.20.3128","article-title":"Nicotine inhaler and nicotine patch as a combination therapy for smoking cessation: a randomized, double-blind, placebo-controlled trial","volume":"160","author":"Bohadana","year":"2000","journal-title":"Arch Intern Med"},{"key":"key20211019135901851_ref1-bib186","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.clinthera.2011.04.013","article-title":"Effects of varenicline in adult smokers: a multinational, 24-week, randomized, double-blind, placebo-controlled study","volume":"33","author":"Bolliger","year":"2011","journal-title":"Clin Ther"},{"key":"key20211019135901851_ref1-bib187","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1159\/000097136","article-title":"A nicotine mouth spray for smoking cessation: a pilot study of preference, safety and efficacy","volume":"74","author":"Bolliger","year":"2007","journal-title":"Respiration"},{"key":"key20211019135901851_ref1-bib188","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1136\/bmj.321.7257.329","article-title":"Smoking reduction with oral nicotine inhalers: double blind, randomised clinical trial of efficacy and safety","volume":"321","author":"Bolliger","year":"2000","journal-title":"BMJ"},{"key":"key20211019135901851_ref1-bib189","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ypmed.2018.04.005","article-title":"Smoking cessation intervention delivered by social service organisations for a diverse population of Australian disadvantaged smokers: a pragmatic randomised controlled trial","volume":"112","author":"Bonevski","year":"2018","journal-title":"Prev Med"},{"key":"key20211019135901851_ref1-bib190","first-page":"825","article-title":"Smokeless tobacco cessation with nicotine replacement: a randomized clinical trial","volume":"54","author":"Boyle","year":"1992","journal-title":"Diss Abstr Int"},{"key":"key20211019135901851_ref1-bib191","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1080\/14622200701416955","article-title":"Bupropion and cognitive-behavioral treatment for depression in smoking cessation","volume":"9","author":"Brown","year":"2007","journal-title":"Nicotine Tob Res"},{"key":"key20211019135901851_ref1-bib192","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1016\/S0140-6736(13)61842-5","article-title":"Electronic cigarettes for smoking cessation: a randomised controlled trial","volume":"382","author":"Bullen","year":"2013","journal-title":"Lancet"},{"key":"key20211019135901851_ref1-bib193","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1111\/j.1360-0443.2010.02989.x","article-title":"Pre-cessation nicotine replacement therapy: pragmatic randomized trial","volume":"105","author":"Bullen","year":"2010","journal-title":"Addiction"},{"key":"key20211019135901851_ref1-bib194","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s12160-015-9732-1","article-title":"Longitudinal care improves cessation in smokers who do not initially respond to treatment by increasing cessation self-efficacy, satisfaction, and readiness to quit: a mediated moderation analysis","volume":"50","author":"Burns","year":"2016","journal-title":"Ann Behav Med"},{"key":"key20211019135901851_ref1-bib195","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1542\/peds.2017-1026M","article-title":"Parental smoking cessation: impacting children\u2019s tobacco smoke exposure in the home","volume":"141","author":"Caldwell","year":"2018","journal-title":"Pediatrics"},{"key":"key20211019135901851_ref1-bib196","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1093\/ntr\/ntu084","article-title":"Combination rapid-acting nicotine mouth spray and nicotine patch therapy in smoking cessation","volume":"16","author":"Caldwell","year":"2014","journal-title":"Nicotine Tob Res"},{"key":"key20211019135901851_ref1-bib197","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1093\/ntr\/ntw093","article-title":"Combination nicotine metered dose inhaler and nicotine patch for smoking cessation: a randomized controlled trial","volume":"18","author":"Caldwell","year":"2016","journal-title":"Nicotine Tob Res"},{"key":"key20211019135901851_ref1-bib198","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1136\/bmj.286.6365.595","article-title":"Comparison of 4 methods of smoking withdrawal in patients with smoking related diseases","volume":"286","author":"Campbell","year":"1983","journal-title":"Br Med J"},{"key":"key20211019135901851_ref1-bib199","first-page":"114","article-title":"Stopping smoking. Do nicotine chewing-gum and postal encouragement add to doctors\u2019 advice","volume":"231","author":"Campbell","year":"1987","journal-title":"Practitioner"},{"key":"key20211019135901851_ref1-bib200","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0954-6111(06)80295-7","article-title":"Smoking cessation in hospital patients given repeated advice plus nicotine or placebo chewing gum","volume":"85","author":"Campbell","year":"1991","journal-title":"Respir Med"},{"key":"key20211019135901851_ref1-bib201","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0954-6111(96)90244-9","article-title":"Transdermal nicotine plus support in patients attending hospital with smoking-related diseases: a placebo-controlled study","volume":"90","author":"Campbell","year":"1996","journal-title":"Respir Med"},{"key":"key20211019135901851_ref1-bib202","doi-asserted-by":"publisher","first-page":"e66317","DOI":"10.1371\/journal.pone.0066317","article-title":"EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study","volume":"8","author":"Caponnetto","year":"2013","journal-title":"PLOS ONE"},{"key":"key20211019135901851_ref1-bib203","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1093\/ntr\/ntu112","article-title":"Safety of varenicline tartrate and counseling versus counseling alone for smoking cessation: a randomized controlled trial for inpatients (STOP study)","volume":"16","author":"Carson","year":"2014","journal-title":"Nicotine Tob Res"},{"key":"key20211019135901851_ref1-bib204","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1111\/j.1360-0443.2011.03363.x","article-title":"A randomized controlled trial of a smoking reduction plus nicotine replacement therapy intervention for smokers not willing to quit smoking","volume":"106","author":"Chan","year":"2011","journal-title":"Addiction"},{"key":"key20211019135901851_ref1-bib205","doi-asserted-by":"publisher","first-page":"765","DOI":"10.4088\/JCP.13m08756","article-title":"Varenicline for smoking cessation in bipolar disorder: a randomized, double-blind, placebo-controlled study","volume":"75","author":"Chengappa","year":"2014","journal-title":"J Clin Psychiatry"},{"key":"key20211019135901851_ref1-bib206","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1037\/\/0022-006x.64.2.314","article-title":"Behavior therapy and the transdermal nicotine patch: effects on cessation outcome, affect, and coping","volume":"64","author":"Cinciripini","year":"1996","journal-title":"J Consult Clin Psychol"},{"key":"key20211019135901851_ref1-bib207","doi-asserted-by":"publisher","DOI":"10.1111\/add.14250","article-title":"An RCT with the combination of varenicline and bupropion for smoking cessation: clinical implications for front line use [published online ahead of print April 21 2018]","author":"Cinciripini","year":"2018","journal-title":"Addiction"},{"key":"key20211019135901851_ref1-bib208","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1001\/jamapsychiatry.2013.678","article-title":"Effects of varenicline and bupropion sustained-release use plus intensive smoking cessation counseling on prolonged abstinence from smoking and on depression, negative affect, and other symptoms of nicotine withdrawal","volume":"70","author":"Cinciripini","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"key20211019135901851_ref1-bib209","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1136\/bmj.291.6508.1538","article-title":"Helping people to stop smoking: randomised comparison of groups being treated with acupuncture and nicotine gum with control group","volume":"291","author":"Clavel","year":"1985","journal-title":"Br Med J"},{"key":"key20211019135901851_ref1-bib210","first-page":"187","article-title":"A randomized 2x2 factorial design to evaluate different smoking cessation methods","volume":"40","author":"Clavelchapelon","year":"1992","journal-title":"Rev Epidemiol Sante Publique"},{"key":"key20211019135901851_ref1-bib211","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/14622200310001656830","article-title":"Gender differences in smoking cessation in a placebo-controlled trial of bupropion with behavioral counseling","volume":"6","author":"Collins","year":"2004","journal-title":"Nicotine Tob Res"},{"key":"key20211019135901851_ref1-bib212","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1111\/j.1360-0443.2009.02624.x","article-title":"Smoking cessation during alcohol treatment: a randomized trial of combination nicotine patch plus nicotine gum","volume":"104","author":"Cooney","year":"2009","journal-title":"Addiction"},{"key":"key20211019135901851_ref1-bib213","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1037\/0893-164X.21.3.277","article-title":"Alcohol and tobacco cessation in alcohol-dependent smokers: analysis of real-time reports","volume":"21","author":"Cooney","year":"2007","journal-title":"Psychol Addict Behav"},{"key":"key20211019135901851_ref1-bib214","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.addbeh.2004.04.013","article-title":"A placebo controlled randomized trial of the effects of phenylpropanolamine and nicotine gum on cessation rates and postcessation weight gain in women","volume":"30","author":"Cooper","year":"2005","journal-title":"Addict Behav"},{"key":"key20211019135901851_ref1-bib215","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1093\/ntr\/ntx189","article-title":"Pilot study of a tailored smoking cessation intervention for individuals in treatment for opioid dependence","volume":"20","author":"Cooperman","year":"2018","journal-title":"Nicotine Tob Res"},{"key":"key20211019135901851_ref1-bib216","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1111\/j.1360-0443.2007.01887.x","article-title":"A randomized trial of bupropion and\/or nicotine gum as maintenance treatment for preventing smoking relapse","volume":"102","author":"Covey","year":"2007","journal-title":"Addiction"},{"key":"key20211019135901851_ref1-bib217","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1093\/jnci\/djr513","article-title":"Bupropion for smoking cessation in African American light smokers: a randomized controlled trial","volume":"104","author":"Cox","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"key20211019135901851_ref1-bib218","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1080\/1462220031000073252","article-title":"Comparison of nicotine patch alone versus nicotine nasal spray alone versus a combination for treating smokers: a minimal intervention, randomized multicenter trial in a nonspecialized setting","volume":"5","author":"Croghan","year":"2003","journal-title":"Nicotine Tob Res"},{"key":"key20211019135901851_ref1-bib219","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.amepre.2015.03.014","article-title":"Race and medication adherence moderate cessation outcomes in criminal justice smokers","volume":"49","author":"Cropsey","year":"2015","journal-title":"Am J Prev Med"},{"key":"key20211019135901851_ref1-bib220","doi-asserted-by":"publisher","first-page":"E16","DOI":"10.1097\/PHH.0b013e3182113871","article-title":"Costs of giving out free nicotine patches through a telephone quit line","volume":"17","author":"Cummings","year":"2011","journal-title":"J Public Health Manag Pract"},{"key":"key20211019135901851_ref1-bib221","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.amepre.2016.06.021","article-title":"Helping hospitalized smokers: a factorial RCT of nicotine patches and counseling","volume":"51","author":"Cummins","year":"2016","journal-title":"Am J Prev Med"},{"key":"key20211019135901851_ref1-bib222","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1001\/jamainternmed.2015.7792","article-title":"Effect of Mailing nicotine patches on tobacco cessation among adult smokers: a randomized clinical trial","volume":"176","author":"Cunningham","year":"2016","journal-title":"JAMA Intern Med"},{"key":"key20211019135901851_ref1-bib223","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.drugalcdep.2007.02.008","article-title":"Bupropion SR for the treatment of smokeless tobacco use","volume":"90","author":"Dale","year":"2007","journal-title":"Drug Alcohol Depend"},{"key":"key20211019135901851_ref1-bib224","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1080\/14622200210153821","article-title":"Bupropion for the treatment of nicotine dependence in spit tobacco users: a pilot study","volume":"4","author":"Dale","year":"2002","journal-title":"Nicotine Tob Res"},{"key":"key20211019135901851_ref1-bib225","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1001\/jama.1995.03530170033028","article-title":"High-dose nicotine patch therapy. Percentage of replacement and smoking cessation","volume":"274","author":"Dale","year":"1995","journal-title":"JAMA"},{"key":"key20211019135901851_ref1-bib226","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/14622200310001656867","article-title":"A multicenter, randomized, double-blind, placebo-controlled, 6-month trial of bupropion hydrochloride sustained-release tablets as an aid to smoking cessation in hospital employees","volume":"6","author":"Dalsgareth","year":"2004","journal-title":"Nicotine Tob Res"},{"key":"key20211019135901851_ref1-bib227","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1001\/archfami.7.5.425","article-title":"Transdermal nicotine therapy and primary care. Importance of counseling, demographic, and participant selection factors on 1-year quit rates. The Nebraska Primary Practice Smoking Cessation Trial Group","volume":"7","author":"Daughton","year":"1998","journal-title":"Arch Fam Med"},{"key":"key20211019135901851_ref1-bib228","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1006\/pmed.1998.0391","article-title":"The smoking cessation efficacy of varying doses of nicotine patch delivery systems 4 to 5 years post-quit day","volume":"28","author":"Daughton","year":"1999","journal-title":"Prev Med"},{"key":"key20211019135901851_ref1-bib229","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1001\/archinte.1991.00400040091020","article-title":"Effect of transdermal nicotine delivery as an adjunct to low-intervention smoking cessation therapy. A randomized, placebo-controlled, double-blind study","volume":"151","author":"Daughton","year":"1991","journal-title":"Arch Intern Med"},{"key":"key20211019135901851_ref1-bib230","first-page":"12s","article-title":"First demonstration of the good efficacy\/safety ratio of Nicotinell\u00ae 1mg lozenge (NL 1mg), a new form of nicotine substitution, by randomised clinical trial","volume":"18","author":"Dautzenberg","year":"2001","journal-title":"Eur Respiratory J"},{"key":"key20211019135901851_ref1-bib231","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1001\/archfami.7.6.569","article-title":"Efficacy and safety of an over-the-counter transdermal nicotine patch as an aid for smoking cessation","volume":"7","author":"Davidson","year":"1998","journal-title":"Arch Fam Med"},{"key":"key20211019135901851_ref1-bib232","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.jsat.2012.01.004","article-title":"Project Impact: a pharmacotherapy pilot trial investigating the abstinence and treatment adherence of Latino light smokers","volume":"43","author":"de Dios","year":"2012","journal-title":"J Subst Abuse Treat"},{"key":"key20211019135901851_ref1-bib233","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1111\/add.14430","article-title":"Varenicline versus placebo for waterpipe smoking cessation: a double-blind randomized controlled trial","volume":"113","author":"Dogar","year":"2018","journal-title":"Addiction"},{"key":"key20211019135901851_ref1-bib234","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1093\/ntr\/ntw123","article-title":"Varenicline for smoking cessation in light smokers","volume":"18","author":"Ebbert","year":"2016","journal-title":"Nicotine Tob Res"},{"key":"key20211019135901851_ref1-bib235","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1093\/ntr\/ntt097","article-title":"A randomized phase II clinical trial of high-dose nicotine patch therapy for smokeless tobacco users","volume":"15","author":"Ebbert","year":"2013","journal-title":"Nicotine Tob Res"},{"key":"key20211019135901851_ref1-bib236","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1093\/ntr\/ntr078","article-title":"A pilot study of the efficacy of varenicline for the treatment of smokeless tobacco users in Midwestern United States","volume":"13","author":"Ebbert","year":"2011","journal-title":"Nicotine Tob Res"},{"key":"key20211019135901851_ref1-bib237","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/14622200601078285","article-title":"Effect of high-dose nicotine patch therapy on tobacco withdrawal symptoms among smokeless tobacco users","volume":"9","author":"Ebbert","year":"2007","journal-title":"Nicotine Tob Res"},{"key":"key20211019135901851_ref1-bib238","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1001\/jama.2013.283185","article-title":"Combination varenicline and bupropion SR for tobacco-dependence treatment in cigarette smokers: a randomized trial","volume":"311","author":"Ebbert","year":"2014","journal-title":"JAMA"},{"key":"key20211019135901851_ref1-bib239","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1001\/jama.2015.280","article-title":"Effect of varenicline on smoking cessation through smoking reduction: a randomized clinical trial","volume":"313","author":"Ebbert","year":"2015","journal-title":"JAMA"},{"key":"key20211019135901851_ref1-bib240","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1093\/ntr\/ntp154","article-title":"A randomized clinical trial of nicotine lozenge for smokeless tobacco use","volume":"11","author":"Ebbert","year":"2009","journal-title":"Nicotine Tob Res"},{"key":"key20211019135901851_ref1-bib241","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.addbeh.2009.12.020","article-title":"A pilot study of mailed nicotine lozenges with assisted self-help for the treatment of smokeless tobacco users","volume":"35","author":"Ebbert","year":"2010","journal-title":"Addict Behav"},{"key":"key20211019135901851_ref1-bib242","first-page":"145","article-title":"Weaning of young smokers using a transdermal nicotine patch","volume":"80","author":"Ehrsam","year":"1991","journal-title":"Schweiz Rundsch Med Prax"},{"key":"key20211019135901851_ref1-bib243","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.jacc.2012.08.1030","article-title":"Bupropion for smoking cessation in patients hospitalized with acute myocardial infarction: a randomized, placebo-controlled trial","volume":"61","author":"Eisenberg","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"key20211019135901851_ref1-bib244","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1161\/CIRCULATIONAHA.115.019634","article-title":"Varenicline for smoking cessation in hospitalized patients with acute coronary syndrome","volume":"133","author":"Eisenberg","year":"2016","journal-title":"Circulation"},{"key":"key20211019135901851_ref1-bib245","doi-asserted-by":"publisher","first-page":"e181843","DOI":"10.1001\/jamanetworkopen.2018.1843","article-title":"Effect of long-term nicotine replacement therapy vs standard smoking cessation for smokers with chronic lung disease: a randomized clinical trial","volume":"1","author":"Ellerbeck","year":"2018","journal-title":"JAMA Netw Open"},{"key":"key20211019135901851_ref1-bib246","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1097\/00004714-200210000-00008","article-title":"Nicotine replacement to reduce cigarette consumption in smokers who are unwilling to quit: a randomized trial","volume":"22","author":"Etter","year":"2002","journal-title":"J Clin Psychopharmacol"},{"key":"key20211019135901851_ref1-bib247","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1001\/archinternmed.2009.12","article-title":"Nicotine gum treatment before smoking cessation: a randomized trial","volume":"169","author":"Etter","year":"2009","journal-title":"Arch Intern Med"},{"key":"key20211019135901851_ref1-bib248","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1097\/01.jcp.0b013e3180ca86fa","article-title":"A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia","volume":"27","author":"Evins","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"key20211019135901851_ref1-bib249","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/01.jcp.0000162802.54076.18","article-title":"A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia","volume":"25","author":"Evins","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"key20211019135901851_ref1-bib250","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1001\/jama.2013.285113","article-title":"Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial","volume":"311","author":"Evins","year":"2014","journal-title":"JAMA"},{"key":"key20211019135901851_ref1-bib251","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1080\/14622200110073920","article-title":"A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia","volume":"3","author":"Evins","year":"2001","journal-title":"Nicotine Tob Res"},{"key":"key20211019135901851_ref1-bib252","doi-asserted-by":"publisher","first-page":"c6549","DOI":"10.1136\/bmj.c6549","article-title":"Stopping smokeless tobacco with varenicline: randomised double blind placebo controlled trial","volume":"341","author":"Fagerstr\u00f6m","year":"2010","journal-title":"BMJ"},{"key":"key20211019135901851_ref1-bib253","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/BF00846161","article-title":"A comparison of psychological and pharmacological treatment in smoking cessation","volume":"5","author":"Fagerstr\u00f6m","year":"1982","journal-title":"J Behav Med"},{"key":"key20211019135901851_ref1-bib254","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/0091-7435(84)90020-3","article-title":"Effects of nicotine chewing gum and follow-up appointments in physician-based smoking cessation","volume":"13","author":"Fagerstr\u00f6m","year":"1984","journal-title":"Prev Med"},{"key":"key20211019135901851_ref1-bib255","first-page":"148","article-title":"A controlled trial of nicotine chewing gum in a smoking withdrawal clinic","volume":"226","author":"Fee","year":"1982","journal-title":"Practitioner"},{"key":"key20211019135901851_ref1-bib256","first-page":"1","article-title":"The more psychology, the better: the efficacy of smoking cessation treatment using intensive cognitive-behavioral therapy versus a combination of nicotine patches plus intensive or less intensive cognitive-behavioral therapy: first prize of the 20th \u2018Rafael Burgaleta\u2019 Applied Psychology Awards 2013","volume":"25","author":"Fernandez Arias","year":"2014","journal-title":"Clinic Salud"},{"key":"key20211019135901851_ref1-bib257","first-page":"249","article-title":"Efficacy of bupropion for smoking cessation in non depressed smokers","volume":"13","author":"Ferry","year":"1994","journal-title":"J Addictive Dis"},{"key":"key20211019135901851_ref1-bib258","first-page":"I","article-title":"Enhancement of smoking cessation using the antidepressant bupropion hydrochloride","volume":"86","author":"Ferry","year":"1992","journal-title":"Circulation"},{"key":"key20211019135901851_ref1-bib259","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1378\/chest.105.2.524","article-title":"Two studies of the clinical effectiveness of the nicotine patch with different counseling treatments","volume":"105","author":"Fiore","year":"1994","journal-title":"Chest"},{"key":"key20211019135901851_ref1-bib260","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.ypmed.2003.11.002","article-title":"Integrating smoking cessation treatment into primary care: an effectiveness study","volume":"38","author":"Fiore","year":"2004","journal-title":"Prev Med"},{"key":"key20211019135901851_ref1-bib261","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1037\/\/0022-006x.63.3.460","article-title":"Nicotine gum and self-help behavioral treatment for smoking relapse prevention: results from a trial using population-based recruitment","volume":"63","author":"Fortmann","year":"1995","journal-title":"J Consult Clin Psychol"},{"key":"key20211019135901851_ref1-bib262","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1001\/archinte.167.16.1791","article-title":"A double-blind, placebo-controlled, randomized trial of bupropion for smoking cessation in primary care","volume":"167","author":"Fossati","year":"2007","journal-title":"Arch Intern Med"},{"key":"key20211019135901851_ref1-bib263","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1111\/add.13855","article-title":"Effect of 0.5\u2009mg versus 1\u2009mg varenicline for smoking cessation: a randomized controlled trial","volume":"112","author":"Fouz-Ros\u00f3n","year":"2017","journal-title":"Addiction"},{"key":"key20211019135901851_ref1-bib264","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1080\/02791072.2007.10399888","article-title":"A comparison of smoking cessation treatments for persons with schizophrenia and other serious mental illnesses","volume":"39","author":"Gallagher","year":"2007","journal-title":"J Psychoactive Drugs"},{"key":"key20211019135901851_ref1-bib265","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jsat.2009.01.006","article-title":"Comparing smoking treatment programs for lighter smokers with and without a history of heavier smoking","volume":"37","author":"Gariti","year":"2009","journal-title":"J Subst Abuse Treat"},{"key":"key20211019135901851_ref1-bib266","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/14622200050011303","article-title":"Effects of nicotine gum dose by level of nicotine dependence","volume":"2","author":"Garvey","year":"2000","journal-title":"Nicotine Tob Res"},{"key":"key20211019135901851_ref1-bib267","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.biopsych.2007.11.002","article-title":"A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia","volume":"63","author":"George","year":"2008","journal-title":"Biol Psychiatry"},{"key":"key20211019135901851_ref1-bib268","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0006-3223(02)01339-2","article-title":"A placebo controlled trial of bupropion for smoking cessation in schizophrenia","volume":"52","author":"George","year":"2002","journal-title":"Biol Psychiatry"},{"key":"key20211019135901851_ref1-bib269","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S0005-7894(04)80015-7","article-title":"Acceptance-based treatment for smoking cessation","volume":"35","author":"Gifford","year":"2004","journal-title":"Behav Ther"},{"key":"key20211019135901851_ref1-bib270","first-page":"49","article-title":"Smoking cessation in primary care. A randomized controlled trial of nicotine-bearing chewing gum","volume":"28","author":"Gilbert","year":"1989","journal-title":"J Fam Pract"},{"key":"key20211019135901851_ref1-bib271","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3109\/10826089209063465","article-title":"Partner support, psychological treatment, and nicotine gum in smoking treatment: an incremental study","volume":"27","author":"Ginsberg","year":"1992","journal-title":"Int J Addict"},{"key":"key20211019135901851_ref1-bib272","first-page":"219","article-title":"Smoking cessation with nicotine replacement therapy among health care workers: randomized double-blind study","volume":"44","author":"Glavas","year":"2003","journal-title":"Croat Med J"},{"key":"key20211019135901851_ref1-bib273","first-page":"8","article-title":"Smoking cessation using the transdermal nicotine system","volume":"125","author":"Glavas","year":"2003","journal-title":"Lijec Vjesn"},{"key":"key20211019135901851_ref1-bib274","volume-title":"Efficacy and Safety Study of Nicotine Mint Lozenge (2mg and 4mg) in Smoking Cessation","author":"GlaxoSmithKline","year":"2009"},{"key":"key20211019135901851_ref1-bib275","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1080\/1462220021000018443","article-title":"A comparison of a nicotine sublingual tablet and placebo for smoking cessation","volume":"4","author":"Glover","year":"2002","journal-title":"Nicotine Tob Res"},{"key":"key20211019135901851_ref1-bib276","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1176\/ajp.146.1.56","article-title":"Effects of behavioral skills training and schedule of nicotine gum administration on smoking cessation","volume":"146","author":"Goldstein","year":"1989","journal-title":"Am J Psychiatry"},{"key":"key20211019135901851_ref1-bib277","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/clpt.2014.124","article-title":"Retreatment with varenicline for smoking cessation in smokers who have previously taken varenicline: a randomized, placebo-controlled trial","volume":"96","author":"Gonzales","year":"2014","journal-title":"Clin Pharmacol Ther"},{"key":"key20211019135901851_ref1-bib278","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1001\/jama.296.1.47","article-title":"Varenicline, an \u03b14\u03b22 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial","volume":"296","author":"Gonzales","year":"2006","journal-title":"JAMA"},{"key":"key20211019135901851_ref1-bib279","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1067\/mcp.2001.115750","article-title":"Bupropion SR as an aid to smoking cessation in smokers treated previously with bupropion: a randomized placebo-controlled study","volume":"69","author":"Gonzales","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"key20211019135901851_ref1-bib280","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1136\/bmj.311.7001.363","article-title":"Effect of treatment for nicotine dependence in patients with COPD","volume":"71","author":"G\u00f3recka","year":"2003","journal-title":"Pneumonol Alergol Pol"},{"key":"key20211019135901851_ref1-bib281","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1136\/bmj.311.7001.363","article-title":"Double blind trial of repeated treatment with transdermal nicotine for relapsed smokers","volume":"311","author":"Gourlay","year":"1995","journal-title":"BMJ"},{"key":"key20211019135901851_ref1-bib282","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1093\/ntr\/ntw282","article-title":"Improving adherence to smoking cessation treatment: intervention effects in a web-based randomized trial","volume":"19","author":"Graham","year":"2017","journal-title":"Nicotine Tob Res"},{"key":"key20211019135901851_ref1-bib283","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.alcohol.2007.03.011","article-title":"Bupropion and nicotine patch as smoking cessation aids in alcoholics","volume":"41","author":"Grant","year":"2007","journal-title":"Alcohol"},{"key":"key20211019135901851_ref1-bib284","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/0306-4603(94)00078-D","article-title":"Dose effects of nicotine gum","volume":"20","author":"Gross","year":"1995","journal-title":"Addict Behav"},{"key":"key20211019135901851_ref1-bib285","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1001\/jamainternmed.2014.6674","article-title":"Proactive tobacco cessation outreach to smokers of low socioeconomic status: a randomized clinical trial","volume":"175","author":"Haas","year":"2015","journal-title":"JAMA Intern Med"},{"key":"key20211019135901851_ref1-bib286","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.pupt.2005.05.003","article-title":"A controlled trial of nortriptyline, sustained-release bupropion and placebo for smoking cessation: preliminary results","volume":"19","author":"Haggstr\u00e4m","year":"2006","journal-title":"Pulm Pharmacol Ther"},{"key":"key20211019135901851_ref1-bib287","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.2105\/AJPH.2010.300084","article-title":"Using extended cognitive behavioral treatment and medication to treat dependent smokers","volume":"101","author":"Hall","year":"2011","journal-title":"Am J Public Health"},{"key":"key20211019135901851_ref1-bib288","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1111\/j.1360-0443.2009.02548.x","article-title":"Extended treatment of older cigarette smokers","volume":"104","author":"Hall","year":"2009","journal-title":"Addiction"},{"key":"key20211019135901851_ref1-bib289","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1001\/archpsyc.59.10.930","article-title":"Psychological intervention and antidepressant treatment in smoking cessation","volume":"59","author":"Hall","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"key20211019135901851_ref1-bib290","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1037\/\/0022-006x.64.5.1003","article-title":"Mood management and nicotine gum in smoking treatment: a therapeutic contact and placebo-controlled study","volume":"64","author":"Hall","year":"1996","journal-title":"J Consult Clin Psychol"},{"key":"key20211019135901851_ref1-bib291","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.2105\/AJPH.2005.080382","article-title":"Treatment for cigarette smoking among depressed mental health outpatients: a randomized clinical trial","volume":"96","author":"Hall","year":"2006","journal-title":"Am J Public Health"},{"key":"key20211019135901851_ref1-bib292","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1037\/\/0022-006x.53.2.256","article-title":"Nicotine gum and behavioral treatment in smoking cessation","volume":"53","author":"Hall","year":"1985","journal-title":"J Consult Clin Psychol"},{"key":"key20211019135901851_ref1-bib293","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1037\/0022-006X.55.4.603","article-title":"Nicotine gum and behavioral treatment: a placebo controlled trial","volume":"55","author":"Hall","year":"1987","journal-title":"J Consult Clin Psychol"},{"key":"key20211019135901851_ref1-bib294","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1056\/NEJMsa1715757","article-title":"A pragmatic trial of e-cigarettes, incentives, and drugs for smoking cessation","volume":"378","author":"Halpern","year":"2018","journal-title":"N Engl J Med"},{"key":"key20211019135901851_ref1-bib295","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1136\/thorax.57.8.715","article-title":"Controlled trial of three weeks nicotine replacement treatment in hospital patients also given advice and support","volume":"57","author":"Hand","year":"2002","journal-title":"Thorax"},{"key":"key20211019135901851_ref1-bib296","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1177\/0022034509350867","article-title":"Intensive smoking-cessation intervention in the dental setting","volume":"89","author":"Hanioka","year":"2010","journal-title":"J Dent Res"},{"key":"key20211019135901851_ref1-bib297","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/0306-4603(88)90038-X","article-title":"Nicotine gum and self-help manuals in smoking cessation: an evaluation in a medical context","volume":"13","author":"Harackiewicz","year":"1988","journal-title":"Addict Behav"},{"key":"key20211019135901851_ref1-bib298","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1037\/\/0022-006x.64.1.153","article-title":"Effects of behavioral and pharmacological treatment on smokeless tobacco users","volume":"64","author":"Hatsukami","year":"1996","journal-title":"J Consult Clin Psychol"},{"key":"key20211019135901851_ref1-bib299","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1037\/0022-006X.68.2.241","article-title":"Treatment of spit tobacco users with transdermal nicotine system and mint snuff","volume":"68","author":"Hatsukami","year":"2000","journal-title":"J Consult Clin Psychol"},{"key":"key20211019135901851_ref1-bib300","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.amjmed.2003.07.018","article-title":"Effects of sustained-release bupropion among persons interested in reducing but not quitting smoking","volume":"116","author":"Hatsukami","year":"2004","journal-title":"Am J Med"},{"key":"key20211019135901851_ref1-bib301","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.2105\/AJPH.89.11.1701","article-title":"Over-the-counter nicotine patch therapy for smoking cessation: results from randomized, double-blind, placebo-controlled, and open label trials","volume":"89","author":"Hays","year":"1999","journal-title":"Am J Public Health"},{"key":"key20211019135901851_ref1-bib302","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1093\/ntr\/ntp077","article-title":"A randomized, controlled trial of bupropion sustained-release for preventing tobacco relapse in recovering alcoholics","volume":"11","author":"Hays","year":"2009","journal-title":"Nicotine Tob Res"},{"key":"key20211019135901851_ref1-bib303","doi-asserted-by":"publisher","first-page":"423","DOI":"10.7326\/0003-4819-135-6-200109180-00011","article-title":"Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. a randomized, controlled trial","volume":"135","author":"Hays","year":"2001","journal-title":"Ann Intern Med"},{"key":"key20211019135901851_ref1-bib304","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1378\/chest.108.2.447","article-title":"Nicotine gum, 2 and 4 mg, for nicotine dependence. A double-blind placebo-controlled trial within a behavior modification support program","volume":"108","author":"Herrera","year":"1995","journal-title":"Chest"},{"key":"key20211019135901851_ref1-bib305","doi-asserted-by":"publisher","first-page":"25","DOI":"10.26719\/2013.19.Supp3.S25","article-title":"Dual addictions, parallel treatments: nicotine replacement therapy for patients receiving methadone treatment in the Islamic Republic of Iran","volume":"19","author":"Heydari","year":"2014","journal-title":"East Mediterr Health J"},{"key":"key20211019135901851_ref1-bib306","doi-asserted-by":"publisher","first-page":"268","DOI":"10.5588\/ijtld.11.0183","article-title":"Quitting smoking with varenicline: parallel, randomised efficacy trial in Iran","volume":"16","author":"Heydari","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"key20211019135901851_ref1-bib307","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.pec.2010.04.009","article-title":"General practice counseling for patients with chronic obstructive pulmonary disease to quit smoking: impact after 1 year of two complex interventions","volume":"83","author":"Hilberink","year":"2011","journal-title":"Patient Educ Couns"},{"key":"key20211019135901851_ref1-bib308","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/j.1552-4604.1994.tb03989.x","article-title":"Comparison of fixed-dose transdermal nicotine, tapered-dose transdermal nicotine, and buspirone in smoking cessation","volume":"34","author":"Hilleman","year":"1994","journal-title":"J Clin Pharmacol"},{"key":"key20211019135901851_ref1-bib309","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1001\/archinte.1994.00420220059007","article-title":"Effect of nicotine nasal spray on smoking cessation. A randomized, placebo-controlled, double-blind study","volume":"154","author":"Hjalmarson","year":"1994","journal-title":"Arch Intern Med"},{"key":"key20211019135901851_ref1-bib310","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1001\/archinte.1997.00440360143016","article-title":"The nicotine inhaler in smoking cessation","volume":"157","author":"Hjalmarson","year":"1997","journal-title":"Arch Intern Med"},{"key":"key20211019135901851_ref1-bib311","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1001\/jama.252.20.2835","article-title":"Effect of nicotine chewing gum in smoking cessation. A randomized, placebo-controlled, double-blind study","volume":"252","author":"Hjalmarson","year":"1984","journal-title":"JAMA"},{"key":"key20211019135901851_ref1-bib312","doi-asserted-by":"publisher","first-page":"i53","DOI":"10.1136\/tc.2006.019794","article-title":"The effectiveness and cost effectiveness of telephone counselling and the nicotine patch in a state tobacco quitline","volume":"16","author":"Hollis","year":"2007","journal-title":"Tob Control"},{"key":"key20211019135901851_ref1-bib313","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1136\/thx.2004.030239","article-title":"Efficacy of bupropion in the indigenous Maori population in New Zealand","volume":"60","author":"Holt","year":"2005","journal-title":"Thorax"},{"key":"key20211019135901851_ref1-bib314","first-page":"349","article-title":"Extended use of nicotine replacement therapy to maintain smoking cessation in persons with schizophrenia","volume":"1","author":"Dale Horst","year":"2005","journal-title":"Neuropsychiatr Dis Treat"},{"key":"key20211019135901851_ref1-bib315","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1037\/1064-1297.7.4.362","article-title":"Quitting chew: results from a randomized trial using nicotine patches","volume":"7","author":"Howard-Pitney","year":"1999","journal-title":"Exp Clin Psychopharmacol"},{"key":"key20211019135901851_ref1-bib316","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1055\/s-2007-1017054","article-title":"Combined and separate treatment effects of nicotine chewing gum and self-control method","volume":"21","author":"Huber","year":"1988","journal-title":"Pharmacopsychiatry"},{"key":"key20211019135901851_ref1-bib317","first-page":"1175","article-title":"Effect of dose on nicotines reinforcing, withdrawal-suppression and self-reported effects","volume":"252","author":"Hughes","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"key20211019135901851_ref1-bib318","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1001\/jama.1989.03420090064032","article-title":"Nicotine vs. placebo gum in general medical practice","volume":"261","author":"Hughes","year":"1989","journal-title":"JAMA"},{"key":"key20211019135901851_ref1-bib319","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/14622299050011281","article-title":"Are higher doses of nicotine replacement more effective for smoking cessation?","volume":"1","author":"Hughes","year":"1999","journal-title":"Nicotine Tob Res"},{"key":"key20211019135901851_ref1-bib320","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1097\/01.ALC.0000071742.86555.4D","article-title":"Efficacy of nicotine patch in smokers with a history of alcoholism","volume":"27","author":"Hughes","year":"2003","journal-title":"Alcohol Clin Exp Res"},{"key":"key20211019135901851_ref1-bib321","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1093\/ntr\/ntr103","article-title":"Efficacy of varenicline to prompt quit attempts in smokers not currently trying to quit: a randomized placebo-controlled trial","volume":"13","author":"Hughes","year":"2011","journal-title":"Nicotine Tob Res"},{"key":"key20211019135901851_ref1-bib322","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.drugalcdep.2010.04.007","article-title":"A randomized, controlled trial of NRT-aided gradual vs. abrupt cessation in smokers actively trying to quit","volume":"111","author":"Hughes","year":"2010","journal-title":"Drug Alcohol Depend"},{"key":"key20211019135901851_ref1-bib323","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1001\/jama.1994.03510320035026","article-title":"Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement","volume":"271","author":"Hurt","year":"1994","journal-title":"JAMA"},{"key":"key20211019135901851_ref1-bib324","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1200\/JCO.2003.08.160","article-title":"Nicotine patch therapy based on smoking rate followed by bupropion for prevention of relapse to smoking","volume":"21","author":"Hurt","year":"2003","journal-title":"J Clin Oncol"},{"key":"key20211019135901851_ref1-bib325","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/S0025-6196(12)62186-7","article-title":"Nicotine-replacement therapy with use of a transdermal nicotine patch \u2013 a randomized double-blind placebo-controlled trial","volume":"65","author":"Hurt","year":"1990","journal-title":"Mayo Clin Proc"},{"key":"key20211019135901851_ref1-bib326","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1056\/NEJM199710233371703","article-title":"A comparison of sustained-release bupropion and placebo for smoking cessation","volume":"337","author":"Hurt","year":"1997","journal-title":"N Engl J Med"},{"key":"key20211019135901851_ref1-bib327","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.drugalcdep.2017.11.017","article-title":"Varenicline for tobacco-dependence treatment in alcohol-dependent smokers: a randomized controlled trial","volume":"184","author":"Hurt","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"key20211019135901851_ref1-bib328","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1136\/bmj.308.6942.1476","article-title":"Randomised trial of nicotine patches in general practice: results at one year","volume":"308","author":"Imperial Cancer Research Fund General Practice Research Group","year":"1994","journal-title":"BMJ"},{"key":"key20211019135901851_ref1-bib329","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.atherosclerosis.2017.05.012","article-title":"Effects of varenicline and nicotine replacement therapy on arterial elasticity, endothelial glycocalyx and oxidative stress during a 3-month smoking cessation program","volume":"262","author":"Ikonomidis","year":"2017","journal-title":"Atherosclerosis"},{"key":"key20211019135901851_ref1-bib330","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1136\/bmj.289.6448.794","article-title":"Placebo controlled trial of nicotine chewing gum in general practice","volume":"289","author":"Jamrozik","year":"1984","journal-title":"Br Med J"},{"key":"key20211019135901851_ref1-bib331","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1136\/bmj.285.6341.537","article-title":"Randomised controlled trial of nicotine chewing-gum","volume":"285","author":"Jarvis","year":"1982","journal-title":"Br Med J"},{"key":"key20211019135901851_ref1-bib332","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3109\/10826089109062156","article-title":"The effect of nicotine, silver acetate, and placebo chewing gum on the cessation of smoking. The influence of smoking type and nicotine dependence","volume":"26","author":"Jensen","year":"1991","journal-title":"Int J Addict"},{"key":"key20211019135901851_ref1-bib333","first-page":"21","article-title":"Randomised controlled trial comparing nicotine replacement therapy (NRT) and counselling on smoking cessation in patients prone to lung cancer using bed font micro-smokerlyzer","volume":"25","author":"Johns","year":"2017","journal-title":"Support Care Cancer"},{"key":"key20211019135901851_ref1-bib334","first-page":"21","article-title":"Randomised controlled trial comparing varenicline plus counselling and brief counselling alone on smoking cessation in patients prone to lung cancer using carbon monoxide moniter","volume":"25","author":"Johns","year":"2017","journal-title":"Support Care Cancer"},{"key":"key20211019135901851_ref1-bib335","doi-asserted-by":"publisher","first-page":"ix177","DOI":"10.1093\/annonc\/mdw600.003","article-title":"Randomised controlled trial comparing nicotine replacement therapy (NRT) plus brief counselling and brief counselling alone on smoking cessation in patients prone to lung cancer using a breath carbon monoxide (CO) monitor","volume":"27","author":"Johns","year":"2016","journal-title":"Ann Oncol"},{"key":"key20211019135901851_ref1-bib336","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1001\/jama.296.1.56","article-title":"Efficacy of varenicline, an \u03b14\u03b22 nicotinic acetylcholine receptor partial agonist, vs. placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial","volume":"296","author":"Jorenby","year":"2006","journal-title":"JAMA"},{"key":"key20211019135901851_ref1-bib337","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1056\/NEJM199903043400903","article-title":"A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation","volume":"340","author":"Jorenby","year":"1999","journal-title":"N Engl J Med"},{"key":"key20211019135901851_ref1-bib338","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1001\/jama.1995.03530170027027","article-title":"Varying nicotine patch dose and type of smoking cessation counseling","volume":"274","author":"Jorenby","year":"1995","journal-title":"JAMA"},{"key":"key20211019135901851_ref1-bib339","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1001\/archinternmed.2011.500","article-title":"Chronic disease management for tobacco dependence: a randomized, controlled trial","volume":"171","author":"Joseph","year":"2011","journal-title":"Arch Intern Med"},{"key":"key20211019135901851_ref1-bib340","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1056\/NEJM199612123352402","article-title":"The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease","volume":"335","author":"Joseph","year":"1996","journal-title":"N Engl J Med"},{"key":"key20211019135901851_ref1-bib341","doi-asserted-by":"publisher","first-page":"681","DOI":"10.15288\/jsa.2004.65.681","article-title":"A randomized trial of concurrent versus delayed smoking intervention for patients in alcohol dependence treatment","volume":"65","author":"Joseph","year":"2004","journal-title":"J Stud Alcohol"},{"key":"key20211019135901851_ref1-bib342","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1111\/j.1475-6773.2008.00891.x","article-title":"The effectiveness of covering smoking cessation services for medicare beneficiaries","volume":"43","author":"Joyce","year":"2008","journal-title":"Health Serv Res"},{"key":"key20211019135901851_ref1-bib343","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.drugalcdep.2011.03.005","article-title":"Incremental efficacy of adding bupropion to the nicotine patch for smoking cessation in smokers with a recent history of alcohol dependence: results from a randomized, double-blind, placebo-controlled study","volume":"118","author":"Kalman","year":"2011","journal-title":"Drug Alcohol Depend"},{"key":"key20211019135901851_ref1-bib344","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jsat.2006.01.001","article-title":"High-dose nicotine patch therapy for smokers with a history of alcohol dependence: 36-week outcomes","volume":"30","author":"Kalman","year":"2006","journal-title":"J Subst Abuse Treat"},{"key":"key20211019135901851_ref1-bib345","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1037\/1064-1297.7.3.226","article-title":"Do heavy smokers benefit from higher dose nicotine patch therapy?","volume":"7","author":"Killen","year":"1999","journal-title":"Exp Clin Psychopharmacol"},{"key":"key20211019135901851_ref1-bib346","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1037\/0022-006x.65.4.663","article-title":"Nicotine patch and self-help video for cigarette smoking cessation","volume":"65","author":"Killen","year":"1997","journal-title":"J Consult Clin Psychol"},{"key":"key20211019135901851_ref1-bib347","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1037\/0022-006X.74.2.286","article-title":"Extended treatment with bupropion SR for cigarette smoking cessation","volume":"74","author":"Killen","year":"2006","journal-title":"J Consult Clin Psychol"},{"key":"key20211019135901851_ref1-bib348","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1037\/\/0022-006x.58.1.85","article-title":"Evaluation of a treatment approach combining nicotine gum with self-guided behavioral treatments for smoking relapse prevention","volume":"58","author":"Killen","year":"1990","journal-title":"J Consult Clin Psychol"},{"key":"key20211019135901851_ref1-bib349","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S0005-7894(84)80026-X","article-title":"Nicotine gum and self-regulation training in smoking relapse prevention","volume":"15","author":"Killen","year":"1984","journal-title":"Behav Ther"},{"key":"key20211019135901851_ref1-bib350","doi-asserted-by":"publisher","first-page":"917","DOI":"10.7205\/MILMED-D-14-00513","article-title":"Efficacy of a tobacco quitline in active duty military and TRICARE beneficiaries: a randomized trial","volume":"180","author":"Klesges","year":"2015","journal-title":"Mil Med"},{"key":"key20211019135901851_ref1-bib351","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1001\/jama.2014.7195","article-title":"Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial","volume":"312","author":"Koegelenberg","year":"2014","journal-title":"JAMA"},{"key":"key20211019135901851_ref1-bib352","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1006\/pmed.1995.1006","article-title":"Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial","volume":"24","author":"Kornitzer","year":"1995","journal-title":"Prev Med"},{"key":"key20211019135901851_ref1-bib353","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0022-3999(87)90073-0","article-title":"A double blind study of 2 mg versus 4 mg nicotine-gum in an industrial setting","volume":"31","author":"Kornitzer","year":"1987","journal-title":"J Psychosom Res"},{"key":"key20211019135901851_ref1-bib354","first-page":"20","article-title":"The clinical benefits of NRT-supported smoking reduction","volume":"4","author":"Kralikova","year":"2002","journal-title":"Nicotine Tob Res"},{"key":"key20211019135901851_ref1-bib355","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1017\/jsc.2014.15","article-title":"Cost and effectiveness of combination nicotine replacement therapy among heavy smokers contacting a quitline","volume":"11","author":"Krupski","year":"2016","journal-title":"J Smoking Cessation"},{"key":"key20211019135901851_ref1-bib356","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1213\/ANE.0b013e318298a6b0","article-title":"The effectiveness of a perioperative smoking cessation program: a randomized clinical trial","volume":"117","author":"Lee","year":"2013","journal-title":"Anesth Analg"},{"key":"key20211019135901851_ref1-bib357","doi-asserted-by":"publisher","first-page":"e5609","DOI":"10.7717\/peerj.5609","article-title":"E-cigarettes versus nicotine patches for perioperative smoking cessation: a pilot randomized trial","volume":"6","author":"Lee","year":"2018","journal-title":"Peer J"},{"key":"key20211019135901851_ref1-bib358","doi-asserted-by":"publisher","first-page":"61","DOI":"10.5993\/AJHB.23.1.7","article-title":"OTC nicotine patch: effectiveness alone and with brief physician intervention","volume":"23","author":"Leischow","year":"1999","journal-title":"Am J Health Behav"},{"key":"key20211019135901851_ref1-bib359","first-page":"364","article-title":"Efficacy of the nicotine inhaler as an adjunct to smoking cessation","volume":"20","author":"Leischow","year":"1996","journal-title":"Am J Health Behav"},{"key":"key20211019135901851_ref1-bib360","doi-asserted-by":"publisher","first-page":"291","DOI":"10.5993\/ajhb.28.4.1","article-title":"Effectiveness of the nicotine inhaler for smoking cessation in an OTC setting","volume":"28","author":"Leischow","year":"2004","journal-title":"Am J Health Behav"},{"key":"key20211019135901851_ref1-bib361","doi-asserted-by":"publisher","first-page":"426","DOI":"10.7326\/0003-4819-140-6-200403160-00009","article-title":"Individualizing nicotine replacement therapy for the treatment of tobacco dependence: a randomized trial","volume":"140","author":"Lerman","year":"2004","journal-title":"Ann Intern Med"},{"key":"key20211019135901851_ref1-bib362","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S2213-2600(14)70294-2","article-title":"Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial","volume":"3","author":"Lerman","year":"2015","journal-title":"Lancet Respir Med"},{"key":"key20211019135901851_ref1-bib363","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1001\/archinternmed.2010.33","article-title":"Bupropion and cognitive behavioral therapy for weight-concerned women smokers","volume":"170","author":"Levine","year":"2010","journal-title":"Arch Intern Med"},{"key":"key20211019135901851_ref1-bib364","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1006\/pmed.1998.0266","article-title":"Transdermal nicotine replacement for hospitalized patients: a randomized clinical trial","volume":"27","author":"Lewis","year":"1998","journal-title":"Prev Med"},{"key":"key20211019135901851_ref1-bib365","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.1007\/s00213-017-4721-7","article-title":"Moderators of smoking cessation outcomes in a randomized-controlled trial of varenicline versus placebo","volume":"234","author":"Littlewood","year":"2017","journal-title":"Psychopharmacology"},{"key":"key20211019135901851_ref1-bib366","first-page":"646","article-title":"Smoking cessation \u2013 effectiveness of nicotine containing chewing gum \u2013 a double-blind trial","volume":"90","author":"Llivina","year":"1988","journal-title":"Med Clin"},{"key":"key20211019135901851_ref1-bib367","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1111\/j.1360-0443.2009.02623.x","article-title":"Motivation and patch treatment for HIV+ smokers: a randomized controlled trial","volume":"104","author":"Lloyd-Richardson","year":"2009","journal-title":"Addiction"},{"key":"key20211019135901851_ref1-bib368","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/BF00427889","article-title":"The use of nicotine chewing gum as an aid to stopping smoking","volume":"70","author":"Malcolm","year":"1980","journal-title":"Psychopharmacology"},{"key":"key20211019135901851_ref1-bib369","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1037\/0022-006x.65.1.190","article-title":"Prospective evaluation of three smoking interventions in 205 recovering alcoholics: one-year results of Project SCRAP-Tobacco","volume":"65","author":"Martin","year":"1997","journal-title":"J Consult Clin Psychol"},{"key":"key20211019135901851_ref1-bib370","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.amepre.2008.04.017","article-title":"Nicotine patches and uninsured quitline callers: a randomized trial of two versus eight weeks","volume":"35","author":"McAfee","year":"2008","journal-title":"Am J Prev Med"},{"key":"key20211019135901851_ref1-bib371","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1080\/14622200801968343","article-title":"A randomized controlled clinical trial of bupropion SR and individual smoking cessation counseling","volume":"10","author":"McCarthy","year":"2008","journal-title":"Nicotine Tob Res"},{"key":"key20211019135901851_ref1-bib372","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/0306-4603(92)90018-Q","article-title":"An assessment of nicotine gum as an adjunct to freedom from smoking cessation clinics","volume":"17","author":"McGovern","year":"1992","journal-title":"Addict Behav"},{"key":"key20211019135901851_ref1-bib373","doi-asserted-by":"publisher","first-page":"e126","DOI":"10.1016\/S2352-3018(18)30002-X","article-title":"Efficacy and safety of varenicline for smoking cessation in people living with HIV in France (ANRS 144 Inter-ACTIV): a randomised controlled phase 3 clinical trial","volume":"5","author":"Merci\u00e9","year":"2018","journal-title":"Lancet HIV"},{"key":"key20211019135901851_ref1-bib374","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1136\/thorax.58.6.484","article-title":"Clinical trial comparing nicotine replacement therapy (NRT) plus brief counselling, brief counselling alone, and minimal intervention on smoking cessation in hospital inpatients","volume":"58","author":"Molyneux","year":"2003","journal-title":"Thorax"},{"key":"key20211019135901851_ref1-bib375","volume-title":"A Clinical Trial of Nicotine Chewing Gum for Smoking Cessation","author":"Mori"},{"key":"key20211019135901851_ref1-bib376","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1111\/j.1365-2044.2004.03943.x","article-title":"Effectiveness of bupropion as an aid to stopping smoking before elective surgery: a randomised controlled trial","volume":"59","author":"Myles","year":"2004","journal-title":"Anaesthesia"},{"key":"key20211019135901851_ref1-bib377","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.3346\/jkms.2007.22.6.1065","article-title":"Sociodemographic and smoking behavioral predictors associated with smoking cessation according to follow-up periods: a randomized, double-blind, placebo-controlled trial of transdermal nicotine patches","volume":"22","author":"Myung","year":"2007","journal-title":"J Korean Med Sci"},{"key":"key20211019135901851_ref1-bib378","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1111\/add.12631","article-title":"Varenicline efficacy and safety among methadone maintained smokers: a randomized placebo-controlled trial","volume":"109","author":"Nahvi","year":"2014","journal-title":"Addiction"},{"key":"key20211019135901851_ref1-bib379","first-page":"665","article-title":"Effect of nicotine chewing gun in smoking cessation classes","author":"Nakamura","year":"1990","journal-title":"Global War"},{"key":"key20211019135901851_ref1-bib380","volume-title":"Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking","author":"Fox Chase Cancer Center, National Cancer Institute","year":"2006"},{"key":"key20211019135901851_ref1-bib381","unstructured":"Pfizer. Long-term Varenicline Treatment for Smoking Cessation. Madison, WI: University of Wisconsin, Madison; 2009. URL: https:\/\/ClinicalTrials.gov\/show\/NCT00828113"},{"key":"key20211019135901851_ref1-bib382","first-page":"263","article-title":"Does nurse counseling or offer of nicotine gum improve the effectiveness of physician smoking-cessation advice?","volume":"12","author":"Nebot","year":"1992","journal-title":"Fam Pract Res J"},{"key":"key20211019135901851_ref1-bib383","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1046\/j.1360-0443.1999.9456856.x","article-title":"Cue exposure treatment for smoking relapse prevention: a controlled clinical trial","volume":"94","author":"Niaura","year":"1999","journal-title":"Addiction"},{"key":"key20211019135901851_ref1-bib384","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1006\/pmed.1994.1010","article-title":"Matching high- and low-dependence smokers to self-help treatment with or without nicotine replacement","volume":"23","author":"Niaura","year":"1994","journal-title":"Prev Med"},{"key":"key20211019135901851_ref1-bib385","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1185\/03007990802177523","article-title":"The efficacy and safety of varenicline for smoking cessation using a flexible dosing strategy in adult smokers: a randomized controlled trial","volume":"24","author":"Niaura","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"key20211019135901851_ref1-bib386","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/ntr\/nty246","article-title":"Efficacy and safety of a nicotine mouth spray for smoking cessation; a randomized, multicenter, controlled study in a naturalistic setting","volume":"18","author":"Nides","year":"2018","journal-title":"Nicotine Tob Res"},{"key":"key20211019135901851_ref1-bib387","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1001\/archinte.166.15.1561","article-title":"Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up","volume":"166","author":"Nides","year":"2006","journal-title":"Arch Intern Med"},{"key":"key20211019135901851_ref1-bib388","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF02599381","article-title":"Increasing the efficacy of physician-delivered smoking interventions: a randomized clinical trial","volume":"6","author":"Ockene","year":"1991","journal-title":"J Gen Intern Med"},{"key":"key20211019135901851_ref1-bib389","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1177\/1090198106288046","article-title":"Pathways to health: a cluster randomized trial of nicotine gum and motivational interviewing for smoking cessation in low-income housing","volume":"34","author":"Okuyemi","year":"2007","journal-title":"Health Educ Behav"},{"key":"key20211019135901851_ref1-bib390","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.addbeh.2006.04.004","article-title":"Transdermal nicotine for smoking cessation in postmenopausal women","volume":"32","author":"Oncken","year":"2007","journal-title":"Addict Behav"},{"key":"key20211019135901851_ref1-bib391","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1001\/archinte.166.15.1571","article-title":"Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation","volume":"166","author":"Oncken","year":"2006","journal-title":"Arch Intern Med"},{"key":"key20211019135901851_ref1-bib392","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.arbres.2010.07.007","article-title":"Effectiveness of a cognitive orientation program with and without nicotine replacement therapy in stopping smoking in hospitalised patients","volume":"47","author":"Ortega","year":"2011","journal-title":"Arch Bronconeumol"},{"key":"key20211019135901851_ref1-bib393","first-page":"237","article-title":"A comparison of the nicotine lozenge and nicotine gum: an effectiveness randomized controlled trial","volume":"107","author":"Pack","year":"2008","journal-title":"WMJ"},{"key":"key20211019135901851_ref1-bib394","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/0306-4603(86)90025-0","article-title":"Smoking cessation in family practice: the effects of advice and nicotine chewing gum prescription","volume":"11","author":"Page","year":"1986","journal-title":"Addict Behav"},{"key":"key20211019135901851_ref1-bib395","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1183\/09031936.96.09040643","article-title":"Importance of baseline cotinine plasma values in smoking cessation: results from a double-blind study with nicotine patch","volume":"9","author":"Paoletti","year":"1996","journal-title":"Eur Respir J"},{"key":"key20211019135901851_ref1-bib396","first-page":"547","article-title":"Randomized, double-blind, placebo-controlled study of transdermal nicotine patch for smoking cessation","volume":"97","author":"Perng","year":"1998","journal-title":"J Formos Med Assoc"},{"key":"key20211019135901851_ref1-bib397","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1093\/abm\/kax059","article-title":"a randomized controlled trial of an optimized smoking treatment delivered in primary care","volume":"52","author":"Piper","year":"2018","journal-title":"Ann Behav Med"},{"key":"key20211019135901851_ref1-bib398","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1080\/14622200701540820","article-title":"Efficacy of bupropion alone and in combination with nicotine gum","volume":"9","author":"Piper","year":"2007","journal-title":"Nicotine Tob Res"},{"key":"key20211019135901851_ref1-bib399","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1001\/archgenpsychiatry.2009.142","article-title":"A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies","volume":"66","author":"Piper","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"key20211019135901851_ref1-bib400","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.2105\/AJPH.82.9.1238","article-title":"Smoking cessation in women concerned about weight","volume":"82","author":"Pirie","year":"1992","journal-title":"Am J Public Health"},{"key":"key20211019135901851_ref1-bib401","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1001\/archinternmed.2011.72","article-title":"Bupropion for smoking cessation in patients with acute coronary syndrome","volume":"171","author":"Planer","year":"2011","journal-title":"Arch Intern Med"},{"key":"key20211019135901851_ref1-bib402","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.addbeh.2006.10.005","article-title":"The effects of exercise and nicotine replacement therapy on smoking rates in women","volume":"32","author":"Prapavessis","year":"2007","journal-title":"Addict Behav"},{"key":"key20211019135901851_ref1-bib403","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0306-4603(79)90048-0","article-title":"Nicotine-containing chewing gum in smoking cessation: a double blind trial with half year follow-up","volume":"4","author":"Puska","year":"1979","journal-title":"Addict Behav"},{"key":"key20211019135901851_ref1-bib404","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1136\/tc.4.3.231","article-title":"Combined use of nicotine patch and gum compared with gum alone in smoking cessation \u2013 a clinical trial in North Karelia","volume":"4","author":"Puska","year":"1995","journal-title":"Tob Control"},{"key":"key20211019135901851_ref1-bib405","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1001\/jama.1994.03520190043033","article-title":"Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study","volume":"272","author":"Anthonisen","year":"1994","journal-title":"JAMA"},{"key":"key20211019135901851_ref1-bib406","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0306-4603(89)90054-3","article-title":"Combination of behavioral smoking cessation with transdermal nicotine substitution","volume":"14","author":"Buchkremer","year":"1989","journal-title":"Addict Behav"},{"key":"key20211019135901851_ref1-bib407","first-page":"215","article-title":"Efficiency of multimodal smoking cessation therapy combining transdermal nicotine substitution with behavioral therapy","volume":"11","author":"Buchkremer","year":"1989","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"key20211019135901851_ref1-bib408","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/archinternmed.2011.492","article-title":"Nicotine therapy sampling to induce quit attempts among smokers unmotivated to quit: a randomized clinical trial","volume":"171","author":"Carpenter","year":"2011","journal-title":"Arch Intern Med"},{"key":"key20211019135901851_ref1-bib409","first-page":"719","article-title":"Double-blind study of the efficacy of nicotine chewing gum for smoking cessation in the primary care setting","volume":"6","author":"Qu\u00edlez Garc\u00eda","year":"1989","journal-title":"Aten Primaria"},{"key":"key20211019135901851_ref1-bib410","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12916-014-0172-8","article-title":"Combining varenicline and nicotine patches: a randomized controlled trial study in smoking cessation","volume":"12","author":"Ramon","year":"2014","journal-title":"BMC Med"},{"key":"key20211019135901851_ref1-bib411","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/nur.20017","article-title":"Efficacy of a smoking-cessation intervention for elective-surgical patients","volume":"27","author":"Ratner","year":"2004","journal-title":"Res Nurs Health"},{"key":"key20211019135901851_ref1-bib412","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jsat.2007.08.010","article-title":"Smoking cessation treatment in community-based substance abuse rehabilitation programs","volume":"35","author":"Reid","year":"2008","journal-title":"J Subst Abuse Treat"},{"key":"key20211019135901851_ref1-bib413","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1097\/00008483-200305000-00003","article-title":"Stepped care approach to smoking cessation in patients hospitalized for coronary artery disease","volume":"23","author":"Reid","year":"2003","journal-title":"J Cardiopulm Rehabil"},{"key":"key20211019135901851_ref1-bib414","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1093\/ntr\/ntr220","article-title":"A randomized placebo-controlled trial of varenicline for smoking cessation allowing flexible quit dates","volume":"14","author":"Rennard","year":"2012","journal-title":"Nicotine Tob Res"},{"key":"key20211019135901851_ref1-bib415","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1080\/14622200600789916","article-title":"Efficacy of the nicotine inhaler in smoking reduction: a double-blind, randomized trial","volume":"8","author":"Rennard","year":"2006","journal-title":"Nicotine Tob Res"},{"key":"key20211019135901851_ref1-bib416","doi-asserted-by":"publisher","first-page":"130","DOI":"10.5694\/j.1326-5377.1994.tb127344.x","article-title":"The transdermal nicotine patch \u2013 results of a randomized placebo-controlled trial","volume":"161","author":"Richmond","year":"1994","journal-title":"Med J Aust"},{"key":"key20211019135901851_ref1-bib417","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/0306-4603(93)90049-F","article-title":"One-year evaluation of three smoking cessation interventions administered by general practitioners","volume":"18","author":"Richmond","year":"1993","journal-title":"Addict Behav"},{"key":"key20211019135901851_ref1-bib418","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1161\/CIRCULATIONAHA.109.869008","article-title":"Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial","volume":"121","author":"Rigotti","year":"2010","journal-title":"Circulation"},{"key":"key20211019135901851_ref1-bib419","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.amjmed.2006.04.024","article-title":"Bupropion for smokers hospitalized with acute cardiovascular disease","volume":"119","author":"Rigotti","year":"2006","journal-title":"Am J Med"},{"key":"key20211019135901851_ref1-bib420","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1136\/oem.60.5.358","article-title":"One year effectiveness of an individualised smoking cessation intervention at the workplace: a randomised controlled trial","volume":"60","author":"Rodr\u00edguez-Artalejo","year":"2003","journal-title":"Occup Environ Med"},{"key":"key20211019135901851_ref1-bib421","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1111\/add.13861","article-title":"Varenicline versus nicotine patch with brief advice for smokers with substance use disorders with or without depression: effects on smoking, substance use and depressive symptoms","volume":"112","author":"Rohsenow","year":"2017","journal-title":"Addiction"},{"key":"key20211019135901851_ref1-bib422","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1176\/appi.ajp.2013.12070919","article-title":"Adapting smoking cessation treatment according to initial response to precessation nicotine patch","volume":"170","author":"Rose","year":"2013","journal-title":"Am J Psychiatry"},{"key":"key20211019135901851_ref1-bib423","first-page":"3445","article-title":"Nicotine gum and withdrawal from smoking","volume":"36","author":"Roto","year":"1987","journal-title":"Suomen Laakarllehtl"},{"key":"key20211019135901851_ref1-bib424","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1177\/1753465809350653","article-title":"Effectiveness of pharmacotherapy and behavioral interventions for smoking cessation in actual clinical practice","volume":"3","author":"Rovina","year":"2009","journal-title":"Ther Adv Respir Dis"},{"key":"key20211019135901851_ref1-bib425","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1136\/bmj.287.6407.1782","article-title":"Effect of nicotine chewing gum as an adjunct to general-practitioners advice against smoking","volume":"287","author":"Russell","year":"1983","journal-title":"Br Med J"},{"key":"key20211019135901851_ref1-bib426","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1001\/archinte.1993.00410160041003","article-title":"Effectiveness of a 16-hour transdermal nicotine patch in a medical practice setting, without intensive group counseling","volume":"153","author":"Sachs","year":"1993","journal-title":"Arch Intern Med"},{"key":"key20211019135901851_ref1-bib427","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1365-2044.2008.05758.x","article-title":"The efficacy of a smoking cessation programme in patients undergoing elective surgery: a randomised clinical trial","volume":"64","author":"Sadr Azodi","year":"2009","journal-title":"Anaesthesia"},{"key":"key20211019135901851_ref1-bib428","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1136\/tc.10.2.175","article-title":"Variations in treatment benefits influence smoking cessation: results of a randomised controlled trial","volume":"10","author":"Schauffler","year":"2001","journal-title":"Tob Control"},{"key":"key20211019135901851_ref1-bib429","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1080\/14622200701365335","article-title":"Bupropion and cognitive-behavioral therapy for smoking cessation in women","volume":"9","author":"Schmitz","year":"2007","journal-title":"Nicotine Tob Res"},{"key":"key20211019135901851_ref1-bib430","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/0306-4603(83)90020-5","article-title":"Nicotine gum in smoking cessation: a placebo-controlled, double-blind trial","volume":"8","author":"Schneider","year":"1983","journal-title":"Addict Behav"},{"key":"key20211019135901851_ref1-bib431","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1046\/j.1360-0443.1995.901216719.x","article-title":"Efficacy of a nicotine nasal spray in smoking cessation: a placebo-controlled, double-blind trial","volume":"90","author":"Schneider","year":"1995","journal-title":"Addiction"},{"key":"key20211019135901851_ref1-bib432","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1111\/j.1360-0443.1996.tb03616.x","article-title":"Efficacy of a nicotine inhaler in smoking cessation: a double-blind, placebo-controlled trial","volume":"91","author":"Schneider","year":"1996","journal-title":"Addiction"},{"key":"key20211019135901851_ref1-bib433","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/pon.4978","article-title":"A randomized controlled trial of 24 weeks of varenicline for tobacco use among cancer patients: efficacy, safety, and adherence","volume":"28","author":"Schnoll","year":"2019","journal-title":"Psycho-Oncology"},{"key":"key20211019135901851_ref1-bib434","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1001\/jamainternmed.2014.8313","article-title":"Long-term nicotine replacement therapy: a randomized clinical trial","volume":"175","author":"Schnoll","year":"2015","journal-title":"JAMA Intern Med"},{"key":"key20211019135901851_ref1-bib435","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s10552-010-9507-8","article-title":"A bupropion smoking cessation clinical trial for cancer patients","volume":"21","author":"Schnoll","year":"2010","journal-title":"Cancer Causes Control"},{"key":"key20211019135901851_ref1-bib436","doi-asserted-by":"publisher","first-page":"144","DOI":"10.7326\/0003-4819-152-3-201002020-00005","article-title":"Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial","volume":"152","author":"Schnoll","year":"2010","journal-title":"Ann Intern Med"},{"key":"key20211019135901851_ref1-bib437","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00052140","article-title":"A randomized trial of smoking cessation interventions in general practice in Italy","volume":"2","author":"Segnan","year":"1991","journal-title":"Cancer Causes Control"},{"key":"key20211019135901851_ref1-bib438","volume-title":"Retreatment with ZYban SR: 52 Week Follow-up of a Canadian Multicentre Trial (POS3-63)","author":"Selby"},{"key":"key20211019135901851_ref1-bib439","doi-asserted-by":"publisher","first-page":"224","DOI":"10.5455\/bcp.20130313045037","article-title":"Comparison of the effectiveness of varenicline, extended-release bupropion and nicotine replacement therapy on the success and the maintenance of a smoking cessation program","volume":"23","author":"Bozkurt Zincir","year":"2013","journal-title":"Bull Clin Psychopharmacol"},{"key":"key20211019135901851_ref1-bib440","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/ntr\/ntu145","article-title":"Randomized trial of nicotine lozenges and phone counseling for smokeless tobacco cessation","volume":"17","author":"Severson","year":"2015","journal-title":"Nicotine Tob Res"},{"key":"key20211019135901851_ref1-bib441","first-page":"1128","article-title":"The effect of individual counseling, line follow-up, and free nicotine replacement therapy on smoking cessation in the samples of Iranian smokers: examination of transtheoretical model","volume":"17","author":"Sharifirad","year":"2012","journal-title":"J Res Med Sci"},{"key":"key20211019135901851_ref1-bib442","doi-asserted-by":"publisher","first-page":"8828","DOI":"10.1038\/s41598-018-26990-5","article-title":"Impact of nicotine replacement therapy as an adjunct to anti-tuberculosis treatment and behaviour change counselling in newly diagnosed pulmonary tuberculosis patients: an open-label, randomised controlled trial","volume":"8","author":"Sharma","year":"2018","journal-title":"Sci Rep"},{"key":"key20211019135901851_ref1-bib443","doi-asserted-by":"publisher","first-page":"550","DOI":"10.7205\/milmed.173.6.550","article-title":"Comparing the tolerability and effectiveness of two treatment regimens in a smoking clinic","volume":"173","author":"Sherman","year":"2008","journal-title":"Mil Med"},{"key":"key20211019135901851_ref1-bib444","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1001\/archinte.162.11.1267","article-title":"Efficacy of a nicotine lozenge for smoking cessation","volume":"162","author":"Shiffman","year":"2002","journal-title":"Arch Intern Med"},{"key":"key20211019135901851_ref1-bib445","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.amepre.2008.09.039","article-title":"Quitting by gradual smoking reduction using nicotine gum: a randomized controlled trial","volume":"36","author":"Shiffman","year":"2009","journal-title":"Am J Prev Med"},{"key":"key20211019135901851_ref1-bib446","doi-asserted-by":"publisher","first-page":"667","DOI":"10.7326\/0003-4819-158-9-201305070-00006","article-title":"Action to stop smoking in suspected tuberculosis (ASSIST) in Pakistan: a cluster randomized, controlled trial","volume":"158","author":"Siddiqi","year":"2013","journal-title":"Ann Intern Med"},{"key":"key20211019135901851_ref1-bib447","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1001\/archinte.164.16.1797","article-title":"Bupropion for smoking cessation: a randomized trial","volume":"164","author":"Simon","year":"2004","journal-title":"Arch Intern Med"},{"key":"key20211019135901851_ref1-bib448","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1093\/ntr\/ntp047","article-title":"Sustained-release bupropion for hospital-based smoking cessation: a randomized trial","volume":"11","author":"Simon","year":"2009","journal-title":"Nicotine Tob Res"},{"key":"key20211019135901851_ref1-bib449","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1001\/archinte.1997.00440330111013","article-title":"Smoking cessation after surgery. A randomized trial","volume":"157","author":"Simon","year":"1997","journal-title":"Arch Intern Med"},{"key":"key20211019135901851_ref1-bib450","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1001\/archinternmed.2009.426","article-title":"Comparative effectiveness of 5 smoking cessation pharmacotherapies in primary care clinics","volume":"169","author":"Smith","year":"2009","journal-title":"Arch Intern Med"},{"key":"key20211019135901851_ref1-bib451","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.ypmed.2004.06.005","article-title":"Does extended proactive telephone support increase smoking cessation among low-income women using nicotine patches?","volume":"40","author":"Solomon","year":"2005","journal-title":"Prev Med"},{"key":"key20211019135901851_ref1-bib452","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1006\/pmed.2000.0683","article-title":"Free nicotine patches plus proactive telephone peer support to help low-income women stop smoking","volume":"31","author":"Solomon","year":"2000","journal-title":"Prev Med"},{"key":"key20211019135901851_ref1-bib453","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/oxfordjournals.aje.a009107","article-title":"Nicotine patches in smoking cessation: a randomized trial among over-the-counter customers in Denmark","volume":"145","author":"S\u00f8nderskov","year":"1997","journal-title":"Am J Epidemiol"},{"key":"key20211019135901851_ref1-bib454","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1111\/add.12304","article-title":"Randomized trial of nicotine replacement therapy (NRT), bupropion and NRT plus bupropion for smoking cessation: effectiveness in clinical practice","volume":"108","author":"Stapleton","year":"2013","journal-title":"Addiction"},{"key":"key20211019135901851_ref1-bib455","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1046\/j.1360-0443.1995.901316.x","article-title":"Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice","volume":"90","author":"Stapleton","year":"1995","journal-title":"Addiction"},{"key":"key20211019135901851_ref1-bib456","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.drugalcdep.2013.07.005","article-title":"Varenicline for smoking cessation among methadone-maintained smokers: a randomized clinical trial","volume":"133","author":"Stein","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"key20211019135901851_ref1-bib457","doi-asserted-by":"publisher","first-page":"447","DOI":"10.7326\/0003-4819-150-7-200904070-00004","article-title":"Triple-combination pharmacotherapy for medically ill smokers: a randomized trial","volume":"150","author":"Steinberg","year":"2009","journal-title":"Ann Intern Med"},{"key":"key20211019135901851_ref1-bib458","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.addbeh.2011.07.002","article-title":"Tobacco dependence treatment for hospitalized smokers: a randomized, controlled, pilot trial using varenicline","volume":"36","author":"Steinberg","year":"2011","journal-title":"Addict Behav"},{"key":"key20211019135901851_ref1-bib459","first-page":"1","article-title":"2014 World Congress Abstracts, 3\u20136 December 2014, Melbourne VIC, Australia","author":"Stockings","year":"2014","journal-title":"Asia Pac J Clin Oncol"},{"key":"key20211019135901851_ref1-bib460","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/0140-6736(92)91403-U","article-title":"Randomised controlled trial of nasal nicotine spray in smoking cessation","volume":"340","author":"Sutherland","year":"1992","journal-title":"Lancet"},{"key":"key20211019135901851_ref1-bib461","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/0091-7435(88)90071-0","article-title":"Smoking intervention in the workplace using videotapes and nicotine chewing gum","volume":"17","author":"Sutton","year":"1988","journal-title":"Prev Med"},{"key":"key20211019135901851_ref1-bib462","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.2105\/AJPH.77.9.1210","article-title":"Randomized trial of brief individual treatment for smoking using nicotine chewing gum in a workplace setting","volume":"77","author":"Sutton","year":"1987","journal-title":"Am J Public Health"},{"key":"key20211019135901851_ref1-bib463","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1093\/milmed\/168.10.830","article-title":"Controlled trial for smoking cessation in a Navy shipboard population using nicotine patch, sustained-release buproprion, or both","volume":"168","author":"Swanson","year":"2003","journal-title":"Mil Med"},{"key":"key20211019135901851_ref1-bib464","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1016\/S0140-6736(00)04724-3","article-title":"Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial","volume":"357","author":"Tashkin","year":"2001","journal-title":"Lancet"},{"key":"key20211019135901851_ref1-bib465","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1378\/chest.10-0865","article-title":"Effects of varenicline on smoking cessation in patients with mild to moderate COPD: a randomized controlled trial","volume":"139","author":"Tashkin","year":"2011","journal-title":"Chest"},{"key":"key20211019135901851_ref1-bib466","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1093\/ntr\/ntq158","article-title":"Brief smoking cessation intervention in relation to breast cancer surgery: a randomized controlled trial","volume":"12","author":"Thomsen","year":"2010","journal-title":"Nicotine Tob Res"},{"key":"key20211019135901851_ref1-bib467","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0306-4603(88)90021-4","article-title":"Two and four mg nicotine chewing gum and group counselling in smoking cessation: an open, randomized, controlled trial with a 22 month follow-up","volume":"13","author":"T\u00f8nnesen","year":"1988","journal-title":"Addict Behav"},{"key":"key20211019135901851_ref1-bib468","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1183\/09031936.00155811","article-title":"Efficacy of a nicotine mouth spray in smoking cessation: a randomised, double-blind trial","volume":"40","author":"T\u00f8nnesen","year":"2012","journal-title":"Eur Respir J"},{"key":"key20211019135901851_ref1-bib469","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1378\/chest.130.2.334","article-title":"Nurse-conducted smoking cessation in patients with COPD using nicotine sublingual tablets and behavioral support","volume":"130","author":"T\u00f8nnesen","year":"2006","journal-title":"Chest"},{"key":"key20211019135901851_ref1-bib470","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1034\/j.1399-3003.2000.16d25.x","article-title":"Smoking cessation with four nicotine replacement regimes in a lung clinic","volume":"16","author":"T\u00f8nnesen","year":"2000","journal-title":"Eur Respir J"},{"key":"key20211019135901851_ref1-bib471","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1001\/jama.1993.03500100066029","article-title":"A double-blind trial of a nicotine inhaler for smoking cessation","volume":"269","author":"T\u00f8nnesen","year":"1993","journal-title":"JAMA"},{"key":"key20211019135901851_ref1-bib472","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJM199108013250503","article-title":"A double-blind trial of a 16-hour transdermal nicotine patch in smoking cessation","volume":"325","author":"T\u00f8nnesen","year":"1991","journal-title":"N Engl J Med"},{"key":"key20211019135901851_ref1-bib473","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1034\/j.1399-3003.1999.13b04.x","article-title":"Higher dosage nicotine patches increase one-year smoking cessation rates: results from the European CEASE trial. Collaborative European Anti-Smoking Evaluation. European Respiratory Society","volume":"13","author":"T\u00f8nnesen","year":"1999","journal-title":"Eur Respir J"},{"key":"key20211019135901851_ref1-bib474","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1046\/j.1365-2796.2003.01185.x","article-title":"A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation","volume":"254","author":"T\u00f8nnesen","year":"2003","journal-title":"J Intern Med"},{"key":"key20211019135901851_ref1-bib475","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/S0195-668X(03)00003-4","article-title":"Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study","volume":"24","author":"Tonstad","year":"2003","journal-title":"Eur Heart J"},{"key":"key20211019135901851_ref1-bib476","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1001\/jama.296.1.64","article-title":"Varenicline Phase 3 Study Group. Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial","volume":"296","author":"Tonstad","year":"2006","journal-title":"JAMA"},{"key":"key20211019135901851_ref1-bib477","first-page":"32","article-title":"Effect of varenicline on smoking cessation in COPD patients recovering from exacerbation: a randomized trial","volume":"32","author":"Tromeur","year":"2018","journal-title":"Fundam Clin Pharmacol"},{"key":"key20211019135901851_ref1-bib478","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.clinthera.2007.06.011","article-title":"A randomized, placebo-controlled trial of varenicline, a selective \u03b14\u03b22 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers","volume":"29","author":"Tsai","year":"2007","journal-title":"Clin Ther"},{"key":"key20211019135901851_ref1-bib479","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1253\/circj.CJ-09-0803","article-title":"A randomized controlled open comparative trial of varenicline vs nicotine patch in adult smokers: efficacy, safety and withdrawal symptoms (the VN-SEESAW study)","volume":"74","author":"Tsukahara","year":"2010","journal-title":"Circ J"},{"key":"key20211019135901851_ref1-bib480","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/bcpt.12548","article-title":"Varenicline and nicotine patch therapies in young adults motivated to quit smoking: a randomized, placebo-controlled, prospective study","volume":"119","author":"Tuisku","year":"2016","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"key20211019135901851_ref1-bib481","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12916-016-0626-2","article-title":"Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial","volume":"14","author":"Tulloch","year":"2016","journal-title":"BMC Med"},{"key":"key20211019135901851_ref1-bib482","volume-title":"A Randomized Trial of Internet Access to Nicotine Patches","author":"University of Michigan, National Heart, Lung and Blood Institute","year":"2011"},{"key":"key20211019135901851_ref1-bib483","first-page":"3347","article-title":"Bupropion together with cognitive-conductual therapy (CBT) is an alternative for a long-term abstinence of smoking","volume":"42","author":"Urdapilleta-Herrera","year":"2013","journal-title":"Eur Respiratory J"},{"key":"key20211019135901851_ref1-bib484","first-page":"922","article-title":"A randomized trial of smoking cessation. Medication versus motivation","volume":"28","author":"Uyar","year":"2007","journal-title":"Saudi Med J"},{"key":"key20211019135901851_ref1-bib485","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/jppr200232157","article-title":"Smoking cessation program using nicotine patches linking hospital to the community","volume":"32","author":"Vial","year":"2002","journal-title":"J Pharmacy Pract Res"},{"key":"key20211019135901851_ref1-bib486","first-page":"107","article-title":"Effectiveness of a multicomponent program to quit smoking with and without nicotine chewing gum","volume":"7","author":"Villa","year":"1999","journal-title":"Psicologia Conductual"},{"key":"key20211019135901851_ref1-bib487","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1001\/archinte.165.19.2286","article-title":"Efficacy of bupropion and nortriptyline for smoking cessation among people who are at risk for or have chronic obstructive pulmonary disease: results from a randomized, placebo-controlled trial","volume":"7","author":"Wagena","year":"2005","journal-title":"Nicotine Tob Res"},{"key":"key20211019135901851_ref1-bib488","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1046\/j.1360-0443.2000.95811613.x","article-title":"A randomized, double-blind, placebo-controlled clinical evaluation of a nicotine sublingual tablet in smoking cessation","volume":"95","author":"Wallstr\u00f6m","year":"2000","journal-title":"Addiction"},{"key":"key20211019135901851_ref1-bib489","doi-asserted-by":"publisher","first-page":"228","DOI":"10.2105\/AJPH.89.2.228","article-title":"Smokeless tobacco cessation intervention for college athletes: results after 1 year","volume":"89","author":"Walsh","year":"1999","journal-title":"Am J Public Health"},{"key":"key20211019135901851_ref1-bib490","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/j.1440-1843.2008.01476.x","article-title":"Varenicline for smoking cessation: a placebo-controlled, randomized study","volume":"14","author":"Wang","year":"2009","journal-title":"Respirology"},{"key":"key20211019135901851_ref1-bib491","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/j.1360-0443.2012.04048.x","article-title":"Randomized trial of the effectiveness of combined behavioral\/pharmacological smoking cessation treatment in Syrian primary care clinics","volume":"108","author":"Ward","year":"2013","journal-title":"Addiction"},{"key":"key20211019135901851_ref1-bib492","first-page":"32","article-title":"Incorporating evidence-based smoking cessation into community oncology practices: feasibility and preliminary efficacy of an enhanced quitline-based smoking cessation intervention for cancer survivors","volume":"24","author":"Weaver","year":"2015","journal-title":"Psycho-Oncology"},{"key":"key20211019135901851_ref1-bib493","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1046\/j.1360-0443.2003.00489.x","article-title":"Smoking reduction promotes smoking cessation: results from a double blind, randomized, placebo-controlled trial of nicotine gum with 2-year follow-up","volume":"98","author":"Wennike","year":"2003","journal-title":"Addiction"},{"key":"key20211019135901851_ref1-bib494","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.rmed.2015.07.017","article-title":"The effect of varenicline on smoking cessation in a group of young asthma patients","volume":"109","author":"Westergaard","year":"2015","journal-title":"Respir Med"},{"key":"key20211019135901851_ref1-bib495","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1001\/archinte.1993.00410160087008","article-title":"The nicotine patch in smoking cessation. A randomized trial with telephone counseling","volume":"153","author":"Westman","year":"1993","journal-title":"Arch Intern Med"},{"key":"key20211019135901851_ref1-bib496","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S1055-3290(06)60353-1","article-title":"The feasibility of a nurse-managed, peer-led tobacco cessation intervention among HIV-positive smokers","volume":"11","author":"Wewers","year":"2000","journal-title":"J Assoc Nurses AIDS Care"},{"key":"key20211019135901851_ref1-bib497","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1097\/hjr.0b013e328010f263","article-title":"The effect of a minimal intervention strategy in addition to nicotine replacement therapy to support smoking cessation in cardiovascular outpatients: a randomized clinical trial","volume":"13","author":"Wiggers","year":"2006","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"key20211019135901851_ref1-bib498","doi-asserted-by":"publisher","first-page":"654","DOI":"10.4088\/JCP.11m07522","article-title":"A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder","volume":"73","author":"Williams","year":"2012","journal-title":"J Clin Psychiatry"},{"key":"key20211019135901851_ref1-bib499","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1185\/030079907x182185","article-title":"A double-blind study evaluating the long-term safety of varenicline for smoking cessation","volume":"23","author":"Williams","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"key20211019135901851_ref1-bib500","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.ijnurstu.2006.10.001","article-title":"Does additional support by nurses enhance the effect of a brief smoking cessation intervention in people with moderate to severe chronic obstructive pulmonary disease? A randomised controlled trial","volume":"45","author":"Wilson","year":"2008","journal-title":"Int J Nurs Stud"},{"key":"key20211019135901851_ref1-bib501","doi-asserted-by":"publisher","first-page":"336","DOI":"10.4088\/JCP.13m08449","article-title":"A randomized trial of concurrent smoking-cessation and substance use disorder treatment in stimulant-dependent smokers","volume":"75","author":"Winhusen","year":"2014","journal-title":"J Clin Psychiatry"},{"key":"key20211019135901851_ref1-bib502","first-page":"66","article-title":"Efficacy of varenicline, an nicotinic acetylcholine receptor partial agonist, vs. placebo for smoking cessation: a randomized controlled trial","volume":"18","author":"Wiratmoko","year":"2013","journal-title":"Respirology"},{"key":"key20211019135901851_ref1-bib503","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/mpr.328","article-title":"Smoking cessation in primary care \u2013 a randomized controlled trial of bupropione, nicotine replacements, CBT and a minimal intervention","volume":"20","author":"Wittchen","year":"2011","journal-title":"Int J Methods Psychiatr Res"},{"key":"key20211019135901851_ref1-bib504","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1046\/j.1360-0443.1999.948122713.x","article-title":"A randomized trial of naltrexone for smoking cessation","volume":"94","author":"Wong","year":"1999","journal-title":"Addiction"},{"key":"key20211019135901851_ref1-bib505","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1213\/ANE.0000000000001894","article-title":"A perioperative smoking cessation intervention with varenicline, counseling, and fax referral to a telephone quitline versus a brief intervention: a randomized controlled trial","volume":"125","author":"Wong","year":"2017","journal-title":"Anesth Analg"},{"key":"key20211019135901851_ref1-bib506","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1097\/ALN.0b013e3182698b42","article-title":"A perioperative smoking cessation intervention with varenicline: a double-blind, randomized, placebo-controlled trial","volume":"117","author":"Wong","year":"2012","journal-title":"Anesthesiology"},{"key":"key20211019135901851_ref1-bib507","first-page":"385","article-title":"[Assessment of efficacy of medication combined with WeChat platform for quitting smoking in patients with chronic obstructive pulmonary disease]","volume":"36","author":"Yang","year":"2016","journal-title":"J Shanghai Jiaotong University (Med Sci)"},{"key":"key20211019135901851_ref1-bib508","first-page":"46","article-title":"The compliance of vanrenicline usage and the smoking abstinence rate via mobile phone text messaging combine with varenicline: a single-blind, randomised control trial","volume":"16","author":"Yuhongxia","year":"2011","journal-title":"Respirology"},{"key":"key20211019135901851_ref1-bib509","doi-asserted-by":"publisher","first-page":"240","DOI":"10.5993\/ajhb.29.3.5","article-title":"Bupropion SR vs. placebo for smoking cessation in health care professionals","volume":"29","author":"Zellweger","year":"2005","journal-title":"Am J Health Behav"},{"key":"key20211019135901851_ref1-bib510","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1037\/\/0022-006x.60.6.943","article-title":"Measures of affect and nicotine dependence predict differential response to smoking cessation treatments","volume":"60","author":"Zelman","year":"1992","journal-title":"J Consult Clin Psychol"},{"key":"key20211019135901851_ref1-bib511","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1111\/j.1360-0443.2008.02348.x","article-title":"A randomized trial of short psychotherapy versus sustained-release bupropion for smoking cessation","volume":"103","author":"Zernig","year":"2008","journal-title":"Addiction"},{"key":"key20211019135901851_ref1-bib512","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1176\/appi.ajp.2010.10040569","article-title":"Effect of nicotine replacement therapy on agitation in smokers with schizophrenia: a double-blind, randomized, placebo-controlled study","volume":"168","author":"Allen","year":"2011","journal-title":"Am J Psychiatry"},{"key":"key20211019135901851_ref1-bib513","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.3950\/jibiinkoka.116.1064","article-title":"Diagnosis and treatment for head and neck cancer-virus association and characterization","volume":"116","author":"Ihara","year":"2013","journal-title":"Nippon Jibiinkoka Gakkai Kaiho"},{"key":"key20211019135901851_ref1-bib514","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1007\/s00213-014-3512-7","article-title":"Effect of varenicline on aspects of inhibitory control in smokers","volume":"231","author":"Austin","year":"2014","journal-title":"Psychopharmacology"},{"key":"key20211019135901851_ref1-bib515","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/j.1553-2712.2011.01097.x","article-title":"A randomized trial of a multicomponent cessation strategy for emergency department smokers","volume":"18","author":"Bernstein","year":"2011","journal-title":"Acad Emerg Med"},{"key":"key20211019135901851_ref1-bib516","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/acem.12990","article-title":"A multicomponent intervention including texting to promote tobacco abstinence in emergency department smokers: a pilot study","volume":"23","author":"Bernstein","year":"2016","journal-title":"Acad Emerg Med"},{"key":"key20211019135901851_ref1-bib517","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.psychres.2008.12.015","article-title":"Preliminary effects of bupropion and the promoter region (HTTLPR) serotonin transporter (SLC6A4) polymorphism on smoking behavior in schizophrenia","volume":"175","author":"Bloch","year":"2010","journal-title":"Psychiatry Res"},{"key":"key20211019135901851_ref1-bib518","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00213-011-2327-z","article-title":"Varenicline effects on craving, cue reactivity, and smoking reward","volume":"218","author":"Brandon","year":"2011","journal-title":"Psychopharmacology"},{"key":"key20211019135901851_ref1-bib519","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/BF00422509","article-title":"Nicotine-containing chewing gum as an anti-smoking aid","volume":"31","author":"Brantmark","year":"1973","journal-title":"Psychopharmacologia"},{"key":"key20211019135901851_ref1-bib520","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1177\/0091270006291837","article-title":"Pharmacokinetics, safety, and tolerability after single and multiple oral doses of varenicline in elderly smokers","volume":"46","author":"Burstein","year":"2006","journal-title":"J Clin Pharmacol"},{"key":"key20211019135901851_ref1-bib521","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1158\/1055-9965.EPI-17-0460","article-title":"A naturalistic, randomized pilot trial of e-cigarettes: uptake, exposure, and behavioral effects","volume":"26","author":"Carpenter","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key20211019135901851_ref1-bib522","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00406-012-0338-3","article-title":"A double-blind randomized clinical trial of different doses of transdermal nicotine patch for smoking reduction and cessation in long-term hospitalized schizophrenic patients","volume":"263","author":"Chen","year":"2013","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"key20211019135901851_ref1-bib523","doi-asserted-by":"publisher","first-page":"594","DOI":"10.14219\/jada.archive.1984.0387","article-title":"Efficacy of nicotine chewing gum in facilitating smoking cessation","volume":"108","author":"Christen","year":"1984","journal-title":"J Am Dent Assoc"},{"key":"key20211019135901851_ref1-bib524","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1037\/pha0000048","article-title":"Experimental study on the effects of anxiety sensitivity and somatosensory amplification on the response to the 35% CO(2) challenge in abstinent smokers","volume":"23","author":"Cosci","year":"2015","journal-title":"Exp Clin Psychopharmacol"},{"key":"key20211019135901851_ref1-bib525","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yrtph.2016.10.003","article-title":"A randomised, parallel group study to evaluate the safety profile of an electronic vapour product over 12 weeks","volume":"81","author":"Cravo","year":"2016","journal-title":"Regul Toxicol Pharmacol"},{"key":"key20211019135901851_ref1-bib526","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13613-018-0399-1","article-title":"The safety and efficacy of nicotine replacement therapy in the intensive care unit: a randomised controlled pilot study","volume":"8","author":"de Jong","year":"2018","journal-title":"Ann Intensive Care"},{"key":"key20211019135901851_ref1-bib527","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1017\/jsc.2014.5","article-title":"A pilot study to investigate the efficacy of nicotine oral soluble film, lozenge and gum in relief of acute smoking cue-provoked craving for cigarette in low dependence smokers","volume":"10","author":"Du","year":"2015","journal-title":"J Smoking Cessation"},{"key":"key20211019135901851_ref1-bib528","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.schres.2013.02.015","article-title":"Antismoking and potential antipsychotic effects of varenicline in subjects with schizophrenia or schizoaffective disorder: a double-blind placebo and bupropion-controlled study","volume":"146","author":"Fatemi","year":"2013","journal-title":"Schizophr Res"},{"key":"key20211019135901851_ref1-bib529","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1001\/archfami.2.4.417","article-title":"Transdermal nicotine patches with low-intensity support to aid smoking cessation in outpatients in a general hospital. A placebo-controlled trial","volume":"2","author":"Foulds","year":"1993","journal-title":"Arch Fam Med"},{"key":"key20211019135901851_ref1-bib530","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s00213-010-2160-9","article-title":"A preliminary investigation of varenicline for heavy drinking smokers","volume":"215","author":"Fucito","year":"2011","journal-title":"Psychopharmacology"},{"key":"key20211019135901851_ref1-bib531","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.biopsych.2010.12.005","article-title":"A double-blind randomized placebo-controlled pilot study of neuropsychiatric adverse events in abstinent smokers treated with varenicline or placebo","volume":"69","author":"Garza","year":"2011","journal-title":"Biol Psychiatry"},{"key":"key20211019135901851_ref1-bib532","volume-title":"Provoked Craving Relief Study by NRT","author":"GlaxoSmithKline","year":"2011"},{"key":"key20211019135901851_ref1-bib533","doi-asserted-by":"publisher","first-page":"386","DOI":"10.5993\/ajhb.26.5.7","article-title":"A comparison of sustained-release bupropion and placebo for smokeless tobacco cessation","volume":"26","author":"Glover","year":"2002","journal-title":"Am J Health Behav"},{"key":"key20211019135901851_ref1-bib534","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1111\/add.12895","article-title":"An exploratory short-term double-blind randomized trial of varenicline versus nicotine patch for smoking cessation in women","volume":"110","author":"Gray","year":"2015","journal-title":"Addiction"},{"key":"key20211019135901851_ref1-bib535","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12971-016-0091-x","article-title":"Effects of varenicline on sympatho-vagal balance and cue reactivity during smoking withdrawal: a randomised placebo-controlled trial","volume":"14","author":"Haarmann","year":"2016","journal-title":"Tob Induc Dis"},{"key":"key20211019135901851_ref1-bib536","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1001\/jamainternmed.2014.6916","article-title":"Increasing varenicline dose in smokers who do not respond to the standard dosage: a randomized clinical trial","volume":"175","author":"Hajek","year":"2015","journal-title":"JAMA Intern Med"},{"key":"key20211019135901851_ref1-bib537","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1001\/archinternmed.2011.138","article-title":"Use of varenicline for 4 weeks before quitting smoking: decrease in ad lib smoking and increase in smoking cessation rates","volume":"171","author":"Hajek","year":"2011","journal-title":"Arch Intern Med"},{"key":"key20211019135901851_ref1-bib538","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/1741-7015-11-140","article-title":"Is a combination of varenicline and nicotine patch more effective in helping smokers quit than varenicline alone? A randomised controlled trial","volume":"11","author":"Hajek","year":"2013","journal-title":"BMC Med"},{"key":"key20211019135901851_ref1-bib539","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/clpt.2011.317","article-title":"The effects of extended pre-quit varenicline treatment on smoking behavior and short-term abstinence: a randomized clinical trial","volume":"91","author":"Hawk","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"key20211019135901851_ref1-bib540","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/adb.12664","article-title":"Varenicline and nabilone in tobacco and cannabis co-users: effects on tobacco abstinence, withdrawal and a laboratory model of cannabis relapse","volume":"24","author":"Herrmann","year":"2019","journal-title":"Addict Biol"},{"key":"key20211019135901851_ref1-bib541","doi-asserted-by":"publisher","first-page":"e895","DOI":"10.1161\/CIR.0b013e31824fcdb3","article-title":"Poster presentations from the World Congress of Cardiology Scientific Sessions 2012","volume":"125","author":"Heydari","year":"2012","journal-title":"Circulation"},{"key":"key20211019135901851_ref1-bib542","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1001\/archgenpsychiatry.2011.83","article-title":"Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder","volume":"68","author":"Hong","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"key20211019135901851_ref1-bib543","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/ntr\/ntt115","article-title":"A double-blind placebo-controlled randomized trial of varenicline for smokeless tobacco dependence in India","volume":"16","author":"Jain","year":"2014","journal-title":"Nicotine Tob Res"},{"key":"key20211019135901851_ref1-bib544","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1093\/eurheartj\/ehu051","article-title":"Effectiveness of a preventive cardiology programme for high CVD risk persistent smokers: the EUROACTION PLUS varenicline trial","volume":"35","author":"Jennings","year":"2014","journal-title":"Eur Heart J"},{"key":"key20211019135901851_ref1-bib545","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3109\/00952990.2011.598591","article-title":"Bupropion-SR for smoking cessation in early recovery from alcohol dependence: a placebo-controlled, double-blind pilot study","volume":"37","author":"Karam-Hage","year":"2011","journal-title":"Am J Drug Alcohol Abuse"},{"key":"key20211019135901851_ref1-bib546","doi-asserted-by":"publisher","DOI":"10.1097\/00006205-199602000-00006","article-title":"A comparison of nicotine delivery systems in a multimodality smoking cessation program","volume":"21","author":"Kupecz","year":"1996","journal-title":"Nurse Pract"},{"key":"key20211019135901851_ref1-bib547","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/00004714-199402000-00006","article-title":"Nicotine skin patch treatment increases abstinence, decreases withdrawal symptoms, and attenuates rewarding effects of smoking","volume":"14","author":"Levin","year":"1994","journal-title":"J Clin Psychopharmacol"},{"key":"key20211019135901851_ref1-bib548","first-page":"231","article-title":"An efficacy analysis of bupropion for smoking cessation in schizophrenia","volume":"28","author":"Li","year":"2009","journal-title":"Zhongguo Xinyao yu Linchuang Zazhi"},{"key":"key20211019135901851_ref1-bib549","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/1745-6215-15-296","article-title":"Nicotine patch preloading for smoking cessation (the preloading trial): study protocol for a randomized controlled trial","volume":"15","author":"Lindson-Hawley","year":"2014","journal-title":"Trials"},{"key":"key20211019135901851_ref1-bib550","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/ADM.0b013e31829623f4","article-title":"A double-blind, placebo-controlled trial assessing the efficacy of varenicline tartrate for alcohol dependence","volume":"7","author":"Litten","year":"2013","journal-title":"J Addict Med"},{"key":"key20211019135901851_ref1-bib551","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1016\/j.clinthera.2005.10.008","article-title":"Safety profile of a nicotine lozenge compared with that of nicotine gum in adult smokers with underlying medical conditions: a 12-week, randomized, open-label study","volume":"27","author":"Marsh","year":"2005","journal-title":"Clin Ther"},{"key":"key20211019135901851_ref1-bib552","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/ntr\/nty047","article-title":"E-cigarettes may support smokers with high smoking-related risk awareness to stop smoking in the short run: preliminary results by randomized controlled trial","volume":"21","author":"Masiero","year":"2019","journal-title":"Nicotine Tob Res"},{"key":"key20211019135901851_ref1-bib553","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/ntr\/nts101","article-title":"Effects of varenicline on abstinence and smoking reward following a programmed lapse","volume":"15","author":"McClure","year":"2013","journal-title":"Nicotine Tob Res"},{"key":"key20211019135901851_ref1-bib554","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.biopsych.2009.01.029","article-title":"Varenicline reduces alcohol self-administration in heavy-drinking smokers","volume":"66","author":"McKee","year":"2009","journal-title":"Biol Psychiatry"},{"key":"key20211019135901851_ref1-bib555","first-page":"476","article-title":"Transdermal nicotine in smoking cessation and involvement of nonspecific influences","volume":"31","author":"Merz","year":"1993","journal-title":"Int J Clin Pharmacol Therapeutics"},{"key":"key20211019135901851_ref1-bib556","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/JCP.0b013e3182870551","article-title":"Varenicline treatment of concurrent alcohol and nicotine dependence in schizophrenia: a randomized, placebo-controlled pilot trial","volume":"33","author":"Meszaros","year":"2013","journal-title":"J Clin Psychopharmacol"},{"key":"key20211019135901851_ref1-bib557","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00213-012-2717-x","article-title":"Varenicline decreases alcohol consumption in heavy-drinking smokers","volume":"223","author":"Mitchell","year":"2012","journal-title":"Psychopharmacology"},{"key":"key20211019135901851_ref1-bib558","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/S0140-6736(02)07369-5","article-title":"Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial","volume":"359","author":"M\u00f8ller","year":"2002","journal-title":"Lancet"},{"key":"key20211019135901851_ref1-bib559","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/clpt.1990.36","article-title":"Clinical and pharmacokinetic properties of a transdermal nicotine patch","volume":"47","author":"Mulligan","year":"1990","journal-title":"Clin Pharmacol Ther"},{"key":"key20211019135901851_ref1-bib560","volume-title":"Trial of Nicotine Nasal Spray as an Aid for Smoking Cessation in Schizophrenia","author":"ClinicalTrials.gov","year":"2009"},{"key":"key20211019135901851_ref1-bib561","volume-title":"Supplemental Nicotine Administration for Smoking Cessation in Posttraumatic Stress Disorder (PTSD)","author":"Duke University","year":"2009"},{"key":"key20211019135901851_ref1-bib562","doi-asserted-by":"publisher","first-page":"69","DOI":"10.5993\/AJHB.42.3.7","article-title":"Nicotine lozenges in the relief of behaviorally provoked craving","volume":"42","author":"Nides","year":"2018","journal-title":"Am J Health Behav"},{"key":"key20211019135901851_ref1-bib563","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1213\/ANE.0b013e3181bd1612","article-title":"A transdermal nicotine patch is not effective for postoperative pain management in smokers: a pilot dose-ranging study","volume":"109","author":"Olson","year":"2009","journal-title":"Anesth Analg"},{"key":"key20211019135901851_ref1-bib564","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1001\/jamapsychiatry.2017.3544","article-title":"Effect of varenicline combined with medical management on alcohol use disorder with comorbid cigarette smoking: a randomized clinical trial","volume":"75","author":"O\u2019Malley","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"key20211019135901851_ref1-bib565","first-page":"399","article-title":"Effect of preoperative smoking intervention on postoperative complications of total hip replacement","volume":"14","author":"Pei","year":"2014","journal-title":"Chin J Evidence-Based Med"},{"key":"key20211019135901851_ref1-bib566","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.drugalcdep.2013.06.019","article-title":"Results from a pilot clinical trial of varenicline for the treatment of alcohol dependence","volume":"133","author":"Plebani","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"key20211019135901851_ref1-bib567","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/j.1521-0391.2010.00066.x","article-title":"The safety and efficacy of varenicline in cocaine using smokers maintained on methadone: a pilot study","volume":"19","author":"Poling","year":"2010","journal-title":"Am J Addict"},{"key":"key20211019135901851_ref1-bib568","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1089\/met.2014.0007","article-title":"Early changes in the components of the metabolic syndrome in a group of smokers after tobacco cessation","volume":"12","author":"Ponciano-Rodriguez","year":"2014","journal-title":"Metab Syndr Relat Disord"},{"key":"key20211019135901851_ref1-bib569","doi-asserted-by":"publisher","first-page":"3843","DOI":"10.1007\/s00213-014-3519-0","article-title":"Varenicline, low dose naltrexone, and their combination for heavy-drinking smokers: human laboratory findings","volume":"231","author":"Ray","year":"2014","journal-title":"Psychopharmacology"},{"key":"key20211019135901851_ref1-bib570","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1001\/archinte.1994.00420090063007","article-title":"Nicotine replacement therapy for patients with coronary-artery disease","volume":"154","author":"Rennard","year":"1994","journal-title":"Arch Intern Med"},{"key":"key20211019135901851_ref1-bib571","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1176\/appi.ajp.2014.13050595","article-title":"Combination treatment with varenicline and bupropion in an adaptive smoking cessation paradigm","volume":"171","author":"Rose","year":"2014","journal-title":"Am J Psychiatry"},{"key":"key20211019135901851_ref1-bib572","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1093\/ntr\/ntw283","article-title":"Combination varenicline\/bupropion treatment benefits highly dependent smokers in an adaptive smoking cessation paradigm","volume":"19","author":"Rose","year":"2017","journal-title":"Nicotine Tob Res"},{"key":"key20211019135901851_ref1-bib573","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1093\/ntr\/ntp103","article-title":"Precessation treatment with nicotine patch significantly increases abstinence rates relative to conventional treatment","volume":"11","author":"Rose","year":"2009","journal-title":"Nicotine Tob Res"},{"key":"key20211019135901851_ref1-bib574","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/clpt.1990.35","article-title":"Transdermal nicotine facilitates smoking cessation","volume":"47","author":"Rose","year":"1990","journal-title":"Clin Pharmacol Ther"},{"key":"key20211019135901851_ref1-bib575","first-page":"1656","article-title":"Effect of nicotine polyestex gum on smoking cessation and quality of life","volume":"91","author":"Rungruanghiranya","year":"2008","journal-title":"J Med Assoc Thai"},{"key":"key20211019135901851_ref1-bib576","volume-title":"Varenicline-aided Cigarette Reduction in Smokers Not Ready to Quit","author":"Rutgers, The State University of New Jersey, Pfizer","year":"2011"},{"key":"key20211019135901851_ref1-bib577","doi-asserted-by":"publisher","first-page":"3799","DOI":"10.1007\/s00213-014-3518-1","article-title":"Varenicline effects on drinking, craving and neural reward processing among non-treatment-seeking alcohol-dependent individuals","volume":"231","author":"Schacht","year":"2014","journal-title":"Psychopharmacology"},{"key":"key20211019135901851_ref1-bib578","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1093\/ntr\/nts129","article-title":"High dose transdermal nicotine for fast metabolizers of nicotine: a proof of concept placebo-controlled trial","volume":"15","author":"Schnoll","year":"2013","journal-title":"Nicotine Tob Res"},{"key":"key20211019135901851_ref1-bib579","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/j.1360-0443.2004.00711.x","article-title":"Effect of pre-treatment with nicotine patch on withdrawal symptoms and abstinence rates in smokers subsequently quitting with the nicotine patch: a randomized controlled trial","volume":"99","author":"Schuurmans","year":"2004","journal-title":"Addiction"},{"key":"key20211019135901851_ref1-bib580","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1093\/ntr\/nts124","article-title":"Sustained-release bupropion for smoking cessation in a Chinese sample: a double-blind, placebo-controlled, randomized trial","volume":"15","author":"Sheng","year":"2013","journal-title":"Nicotine Tob Res"},{"key":"key20211019135901851_ref1-bib581","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1037\/0022-006X.74.2.276","article-title":"Analyzing milestones in smoking cessation: illustration in a nicotine patch trial in adult smokers","volume":"74","author":"Shiffman","year":"2006","journal-title":"J Consult Clin Psychol"},{"key":"key20211019135901851_ref1-bib582","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/npp.2011.238","article-title":"Adjunctive varenicline treatment with antipsychotic medications for cognitive impairments in people with schizophrenia: a randomized double-blind placebo-controlled trial","volume":"37","author":"Shim","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"key20211019135901851_ref1-bib583","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.drugalcdep.2008.03.010","article-title":"Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence","volume":"96","author":"Shoptaw","year":"2008","journal-title":"Drug Alcohol Depend"},{"key":"key20211019135901851_ref1-bib584","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4103\/0970-2113.59262","article-title":"Assessment of the effectiveness of sustained release bupropion and intensive physician advice in smoking cessation","volume":"27","author":"Singh","year":"2010","journal-title":"Lung India"},{"key":"key20211019135901851_ref1-bib585","doi-asserted-by":"publisher","first-page":"e0143490","DOI":"10.1371\/journal.pone.0143490","article-title":"Varenicline effects on smoking, cognition, and psychiatric symptoms in schizophrenia: a double-blind randomized trial","volume":"11","author":"Smith","year":"2016","journal-title":"PLOS ONE"},{"key":"key20211019135901851_ref1-bib586","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1046\/j.1463-1318.2003.00450.x","article-title":"Short-term pre-operative smoking cessation intervention does not affect postoperative complications in colorectal surgery: a randomized clinical trial","volume":"5","author":"Sorensen","year":"2003","journal-title":"Colorectal Dis"},{"key":"key20211019135901851_ref1-bib587","volume-title":"Nicotine Replacement Therapy (NRT) and Bupropion Mechanisms of Effectiveness in Smokers","author":"Southern Illinois University Carbondale, National Institute on Drug Abuse","year":"2005"},{"key":"key20211019135901851_ref1-bib588","volume-title":"Varenicline In-Patient Study","author":"Stanford University, Pfizer","year":"2011"},{"key":"key20211019135901851_ref1-bib589","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1111\/j.1360-0443.2010.03274.x","article-title":"Treating heavy smokers in primary care with the nicotine nasal spray: randomized placebo-controlled trial","volume":"106","author":"Stapleton","year":"2011","journal-title":"Addiction"},{"key":"key20211019135901851_ref1-bib590","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.addbeh.2018.03.026","article-title":"Varenicline for smoking reduction in smokers not yet ready to quit: a double-blind, proof-of-concept randomized clinical trial","volume":"84","author":"Steinberg","year":"2018","journal-title":"Addict Behav"},{"key":"key20211019135901851_ref1-bib591","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/S0893-133X(00)00217-7","article-title":"The effects of transdermal nicotine therapy for smoking cessation on depressive symptoms in patients with major depression","volume":"24","author":"Thorsteinsson","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"key20211019135901851_ref1-bib592","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00213-011-2282-8","article-title":"Effects of contingency management and bupropion on cigarette smoking in smokers with schizophrenia","volume":"217","author":"Tidey","year":"2011","journal-title":"Psychopharmacology"},{"key":"key20211019135901851_ref1-bib593","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1093\/ntr\/ntw017","article-title":"A randomized trial comparing the effect of nicotine versus placebo electronic cigarettes on smoking reduction among young adult smokers","volume":"18","author":"Tseng","year":"2016","journal-title":"Nicotine Tob Res"},{"key":"key20211019135901851_ref1-bib594","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1023\/a:1007757530765","article-title":"Cardiovascular safety of transdermal nicotine patches in patients with coronary artery disease who try to quit smoking","volume":"12","author":"Tzivoni","year":"1998","journal-title":"Cardiovasc Drugs Ther"},{"key":"key20211019135901851_ref1-bib595","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1037\/0022-006X.74.6.1162","article-title":"Evaluating nicotine replacement therapy and stage-based therapies in a population-based effectiveness trial","volume":"74","author":"Velicer","year":"2006","journal-title":"J Consult Clin Psychol"},{"key":"key20211019135901851_ref1-bib596","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1097\/ADM.0000000000000208","article-title":"Effect of lowering the dose of varenicline on alcohol self-administration in drinkers with alcohol use disorders","volume":"10","author":"Verplaetse","year":"2016","journal-title":"J Addict Med"},{"key":"key20211019135901851_ref1-bib597","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1097\/00000542-200506000-00013","article-title":"Effect of nicotine replacement therapy on stress and smoking behavior in surgical patients","volume":"102","author":"Warner","year":"2005","journal-title":"Anesthesiology"},{"key":"key20211019135901851_ref1-bib598","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/JCP.0b013e318184ba3c","article-title":"A preliminary study of sustained-release bupropion for smoking cessation in bipolar disorder","volume":"28","author":"Weinberger","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"key20211019135901851_ref1-bib599","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4088\/JCP.10m06143gre","article-title":"Bupropion sustained release added to group support for smoking cessation in schizophrenia: a new randomized trial and a meta-analysis","volume":"73","author":"Weiner","year":"2012","journal-title":"J Clin Psychiatry"},{"key":"key20211019135901851_ref1-bib600","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.schres.2011.02.003","article-title":"Varenicline for smoking cessation in people with schizophrenia: a double blind randomized pilot study","volume":"129","author":"Weiner","year":"2011","journal-title":"Schizophr Res"},{"key":"key20211019135901851_ref1-bib601","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1472-6831-12-13","article-title":"Randomized controlled trial to evaluate tooth stain reduction with nicotine replacement gum during a smoking cessation program","volume":"12","author":"Whelton","year":"2012","journal-title":"BMC Oral Health"},{"key":"key20211019135901851_ref1-bib602","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/j.1365-2044.2004.04070.x","article-title":"A programme for reducing smoking in pre-operative surgical patients: randomised controlled trial","volume":"60","author":"Wolfenden","year":"2005","journal-title":"Anaesthesia"},{"key":"key20211019135901851_ref1-bib603","volume-title":"The Effect of Varenicline (Chantix) and Bupropion (Zyban) on Smoking Lapse Behavior","author":"Yale University, National Institute on Alcohol Abuse and Alcoholism","year":"2007"},{"key":"key20211019135901851_ref1-bib604","unstructured":"Zhu J. The Effectiveness of Bupropion SR on Depressive Symptoms in Smokers: Self-Reports, EEG, and Individual Differences. PhD Thesis. Cabondale, IL, Southern Illinois University; 2015."},{"key":"key20211019135901851_ref1-bib605","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/14622200500124768","article-title":"Adverse effects of pharmacological therapy for nicotine addiction in smokers following a smoking cessation program","volume":"7","author":"Barrueco","year":"2005","journal-title":"Nicotine Tob Res"},{"key":"key20211019135901851_ref1-bib606","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1378\/chest.129.4.979","article-title":"\u2018Tobacco Free With FDNY\u2019: the New York City Fire Department World Trade Center Tobacco Cessation Study","volume":"129","author":"Bars","year":"2006","journal-title":"Chest"},{"key":"key20211019135901851_ref1-bib607","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1097\/CCM.0b013e31821867b8","article-title":"Nicotine replacement therapy in critically ill patients: a prospective observational cohort study","volume":"39","author":"Cartin-Ceba","year":"2011","journal-title":"Crit Care Med"},{"key":"key20211019135901851_ref1-bib608","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1111\/add.13329","article-title":"A comparison of neuropsychiatric adverse events during early treatment with varenicline or a nicotine patch","volume":"111","author":"Cunningham","year":"2016","journal-title":"Addiction"},{"key":"key20211019135901851_ref1-bib609","doi-asserted-by":"publisher","first-page":"e009665","DOI":"10.1136\/bmjopen-2015-009665","article-title":"What are the effects of varenicline compared with nicotine replacement therapy on long-term smoking cessation and clinically important outcomes? Protocol for a prospective cohort study","volume":"5","author":"Davies","year":"2015","journal-title":"BMJ Open"},{"key":"key20211019135901851_ref1-bib610","first-page":"63","article-title":"One-year follow up results of Smoking Cessation Outpatient Clinic","volume":"52","author":"Demir","year":"2004","journal-title":"Tuberk Toraks"},{"key":"key20211019135901851_ref1-bib611","doi-asserted-by":"publisher","first-page":"80","DOI":"10.5152\/ejp.2016.69885","article-title":"Two-years follow-up results of a smoking cessation clinic in a state hospital","volume":"18","author":"Deniz","year":"2016","journal-title":"Eurasian J Pulmonol"},{"key":"key20211019135901851_ref1-bib612","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.ejim.2012.03.017","article-title":"Effectiveness of varenicline for smoking cessation at 2 urban academic health centers","volume":"23","author":"Dhelaria","year":"2012","journal-title":"Eur J Intern Med"},{"key":"key20211019135901851_ref1-bib613","doi-asserted-by":"publisher","first-page":"231","DOI":"10.2147\/CLEP.S127775","article-title":"Cardiovascular risks in smokers treated with nicotine replacement therapy: a historical cohort study","volume":"9","author":"Dollerup","year":"2017","journal-title":"Clin Epidemiol"},{"key":"key20211019135901851_ref1-bib614","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1093\/ntr\/ntp042","article-title":"Combination treatment with varenicline and nicotine replacement therapy","volume":"11","author":"Ebbert","year":"2009","journal-title":"Nicotine Tob Res"},{"key":"key20211019135901851_ref1-bib615","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/ntr\/nts121","article-title":"Safety of varenicline among smokers enrolled in the lung HIV study","volume":"15","author":"Ferketich","year":"2013","journal-title":"Nicotine Tob Res"},{"key":"key20211019135901851_ref1-bib616","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.schres.2016.05.011","article-title":"It is feasible and effective to help patients with severe mental disorders to quit smoking: an ecological pragmatic clinical trial with transdermal nicotine patches and varenicline","volume":"176","author":"Garcia-Portilla","year":"2016","journal-title":"Schizophr Res"},{"key":"key20211019135901851_ref1-bib617","first-page":"P4048","article-title":"Differences between the recommended and real dose in a smoking cessation practice","volume":"40","author":"Gomez-Bastero","year":"2012","journal-title":"Eur Respir J"},{"key":"key20211019135901851_ref1-bib618","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1002\/pds.3678","article-title":"Cardiovascular and mortality risks in older Medicare patients treated with varenicline or bupropion for smoking cessation: an observational cohort study","volume":"23","author":"Graham","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"key20211019135901851_ref1-bib619","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.mayocp.2013.05.027","article-title":"Outcomes from a patient-centered residential treatment plan for tobacco dependence","volume":"88","author":"Hodgkin","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"key20211019135901851_ref1-bib620","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1007\/s00213-014-3482-9","article-title":"Varenicline versus transdermal nicotine patch: a 3-year follow-up in a smoking cessation clinic in Taiwan","volume":"231","author":"Hsueh","year":"2014","journal-title":"Psychopharmacology"},{"key":"key20211019135901851_ref1-bib621","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1177\/0163278712466868","article-title":"A comparison of the effectiveness of varenicline and transdermal nicotine patch in outpatients following a standardized smoking cessation program in Southern Taiwan","volume":"38","author":"Hsueh","year":"2015","journal-title":"Eval Health Prof"},{"key":"key20211019135901851_ref1-bib622","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0300-2896(15)30197-6","article-title":"Individual treatment of smoking addiction. Results using 2 and 4 mg nicotine gum","volume":"36","author":"Jim\u00e9nez Ruiz","year":"2000","journal-title":"Arch Bronconeumol"},{"key":"key20211019135901851_ref1-bib623","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1093\/ntr\/nts001","article-title":"Characteristics of COPD smokers and effectiveness and safety of smoking cessation medications","volume":"14","author":"Jim\u00e9nez Ruiz","year":"2012","journal-title":"Nicotine Tob Res"},{"key":"key20211019135901851_ref1-bib624","doi-asserted-by":"publisher","DOI":"10.1016\/j.rppnen.2017.10.008","article-title":"Effectiveness and safety of varenicline and nicotine replacement therapy among mental health patients: a retrospective cohort study [published online ahead of print December 21 2017]","author":"Jim\u00e9nez-Ruiz","year":"2017","journal-title":"Pulmonology"},{"key":"key20211019135901851_ref1-bib625","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/ADM.0000000000000111","article-title":"Real-world effectiveness of varenicline versus nicotine replacement therapy in patients with and without psychiatric disorders","volume":"9","author":"Kaduri","year":"2015","journal-title":"J Addict Med"},{"key":"key20211019135901851_ref1-bib626","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1177\/0310057X1604400621","article-title":"Safety of nicotine replacement therapy in critically ill smokers: a retrospective cohort study","volume":"44","author":"Kerr","year":"2016","journal-title":"Anaesth Intensive Care"},{"key":"key20211019135901851_ref1-bib627","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.4187\/respcare.03883","article-title":"Relapse rate and factors related to relapse in a 1-year follow-up of subjects participating in a smoking cessation program","volume":"60","author":"Ko\u00e7ak","year":"2015","journal-title":"Respir Care"},{"key":"key20211019135901851_ref1-bib628","first-page":"839","article-title":"Safety of nicotine addiction treatment","volume":"70","author":"Korzeniowska","year":"2013","journal-title":"Prz Lek"},{"key":"key20211019135901851_ref1-bib629","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1136\/thoraxjnl-2017-210067","article-title":"Cardiovascular and neuropsychiatric risks of varenicline and bupropion in smokers with chronic obstructive pulmonary disease","volume":"72","author":"Kotz","year":"2017","journal-title":"Thorax"},{"key":"key20211019135901851_ref1-bib630","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1097\/01.CCM.0000266537.86437.38","article-title":"The association of nicotine replacement therapy with mortality in a medical intensive care unit","volume":"35","author":"Lee","year":"2007","journal-title":"Crit Care Med"},{"key":"key20211019135901851_ref1-bib631","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.aprim.2010.09.010","article-title":"Abstinence rates with varenicline compared to bupropion and nicotine replacement therapy for quitting smoking in primary care","volume":"43","author":"Sicras Mainar","year":"2011","journal-title":"Aten Primaria"},{"key":"key20211019135901851_ref1-bib632","doi-asserted-by":"publisher","first-page":"e0129443","DOI":"10.1371\/journal.pone.0129443","article-title":"Electronic cigarettes efficacy and safety at 12 months: cohort study","volume":"10","author":"Manzoli","year":"2015","journal-title":"PLOS ONE"},{"key":"key20211019135901851_ref1-bib633","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.amjcard.2004.12.039","article-title":"Safety and effectiveness of transdermal nicotine patch in smokers admitted with acute coronary syndromes","volume":"95","author":"Meine","year":"2005","journal-title":"Am J Cardiol"},{"key":"key20211019135901851_ref1-bib634","doi-asserted-by":"publisher","first-page":"h2388","DOI":"10.1136\/bmj.h2388","article-title":"Varenicline and risk of psychiatric conditions, suicidal behaviour, criminal offending, and transport accidents and offences: population based cohort study","volume":"350","author":"Molero","year":"2015","journal-title":"BMJ"},{"key":"key20211019135901851_ref1-bib635","first-page":"354","article-title":"The comparison of nicotine replacement therapy and behavioral education in smoking cessation: a study of naturalistic follow-up","volume":"53","author":"Orsel","year":"2005","journal-title":"Tuberk Toraks"},{"key":"key20211019135901851_ref1-bib636","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/ntr\/ntp005","article-title":"Adverse effects with use of nicotine replacement therapy among quitline clients","volume":"11","author":"Ossip","year":"2009","journal-title":"Nicotine Tob Res"},{"key":"key20211019135901851_ref1-bib637","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.2146\/ajhp090402","article-title":"Outcomes associated with transdermal nicotine replacement therapy in a neurosurgery intensive care unit","volume":"67","author":"Panos","year":"2010","journal-title":"Am J Health Syst Pharm"},{"key":"key20211019135901851_ref1-bib638","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1111\/add.12165","article-title":"Use of varenicline versus bupropion and risk of psychiatric adverse events","volume":"108","author":"Pasternak","year":"2013","journal-title":"Addiction"},{"key":"key20211019135901851_ref1-bib639","doi-asserted-by":"publisher","first-page":"345","DOI":"10.4067\/S0034-98872013000300010","article-title":"Results of a multidisciplinary program to quit smoking","volume":"141","author":"Pe\u00f1a","year":"2013","journal-title":"Rev Med Chil"},{"key":"key20211019135901851_ref1-bib640","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1177\/1479972317740128","article-title":"Effects of varenicline therapy in combination with advanced behavioral support on smoking cessation and quality of life in inpatients with acute exacerbation of COPD, bronchial asthma, or community-acquired pneumonia: a prospective, open-label, preference-based, 52-week, follow-up trial","volume":"15","author":"Politis","year":"2018","journal-title":"Chron Respir Dis"},{"key":"key20211019135901851_ref1-bib641","doi-asserted-by":"crossref","volume-title":"Pharmacotherapy for Smoking Cessation \u2013 The Experience of a Smoking Cessation Center","author":"Postolache","DOI":"10.1109\/EHB.2013.6707332"},{"key":"key20211019135901851_ref1-bib642","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1592\/phco.25.2.279.56957","article-title":"Outcomes from an outpatient smoking-cessation clinic","volume":"25","author":"Roth","year":"2005","journal-title":"Pharmacotherapy"},{"key":"key20211019135901851_ref1-bib643","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1007\/s12630-012-9716-6","article-title":"Smoking cessation interventions in the pre-admission clinic: assessing two approaches","volume":"59","author":"Sachs","year":"2012","journal-title":"Can J Anaesth"},{"key":"key20211019135901851_ref1-bib644","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1080\/1462220031000118702","article-title":"Smoking cessation treatment among dually diagnosed individuals: preliminary evaluation of different pharmacotherapies","volume":"5","author":"Saxon","year":"2003","journal-title":"Nicotine Tob Res"},{"key":"key20211019135901851_ref1-bib645","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1375\/jsc.6.1.65","article-title":"A retrospective comparison of varenicline monotherapy versus the combination of varenicline and bupropion or bupropion and nicotine patches in a VA tobacco cessation clinic","volume":"6","author":"Shiltz","year":"2012","journal-title":"J Smoking Cessation"},{"key":"key20211019135901851_ref1-bib646","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1360-0443.2007.02083.x","article-title":"Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness","volume":"103","author":"Stapleton","year":"2008","journal-title":"Addiction"},{"key":"key20211019135901851_ref1-bib647","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.drugalcdep.2010.06.022","article-title":"Abstinence and psychological distress in co-morbid smokers using various pharmacotherapies","volume":"114","author":"Steinberg","year":"2011","journal-title":"Drug Alcohol Depend"},{"key":"key20211019135901851_ref1-bib648","doi-asserted-by":"publisher","first-page":"e7176","DOI":"10.1136\/bmj.e7176","article-title":"Use of varenicline for smoking cessation and risk of serious cardiovascular events: nationwide cohort study","volume":"345","author":"Svanstr\u00f6m","year":"2012","journal-title":"BMJ"},{"key":"key20211019135901851_ref1-bib649","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1445-5994.2011.02442.x","article-title":"Smoking cessation post-discharge following nicotine replacement therapy use during an inpatient admission","volume":"42","author":"Williams","year":"2012","journal-title":"Intern Med J"},{"key":"key20211019135901851_ref1-bib650","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1071\/he08158","article-title":"Pilot of a preoperative smoking cessation intervention incorporating post-discharge support from a Quitline","volume":"19","author":"Wolfenden","year":"2008","journal-title":"Health Promot J Austr"},{"key":"key20211019135901851_ref1-bib651","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.amjcard.2012.05.028","article-title":"Effect of nicotine replacement therapy on cardiovascular outcomes after acute coronary syndromes","volume":"110","author":"Woolf","year":"2012","journal-title":"Am J Cardiol"},{"key":"key20211019135901851_ref1-bib652","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s11684-014-0311-9","article-title":"Nicotine gum or patch treatment for smoking cessation and smoking reduction: a multi-centre study in Chinese physicians","volume":"8","author":"Xiao","year":"2014","journal-title":"Front Med"},{"key":"key20211019135901851_ref1-bib653","doi-asserted-by":"publisher","first-page":"A1","DOI":"10.1111\/wrr.12622","article-title":"30(th) Annual Meeting of the Wound Healing Society SAWC-Spring\/WHS Joint Meeting: Charlotte Convention Center, Charlotte, North Carolina, USA, April 25\u201329, 2018","volume":"26","author":"Xu","year":"2018","journal-title":"Wound Repair Regen"},{"key":"key20211019135901851_ref1-bib654","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/ijcp.12363","article-title":"The long-term cost-effectiveness of varenicline (12-week standard course and 12\u2009+\u200912-week extended course) vs. other smoking cessation strategies in Canada","volume":"68","author":"von Wartburg","year":"2014","journal-title":"Int J Clin Pract"},{"key":"key20211019135901851_ref1-bib655","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/j.clinthera.2012.07.002","article-title":"Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece","volume":"34","author":"Athanasakis","year":"2012","journal-title":"Clin Ther"},{"key":"key20211019135901851_ref1-bib656","volume-title":"The Tobacco and Related Products Regulations 2016","author":"Great Britain","year":"2016"},{"key":"key20211019135901851_ref1-bib657","volume-title":"Guidance: Licensing Procedure for Electronic Cigarettes as Medicines","author":"Medicines and Healthcare products Regulatory Agency","year":"2017"},{"key":"key20211019135901851_ref1-bib658","unstructured":"Office for National Statistics (ONS). Registrations of Cancer Diagnosed in 2003, England. Newport: ONS; 2005."},{"key":"key20211019135901851_ref1-bib659","unstructured":"British Heart Foundation. Coronary Heart Disease Statistics Fact Sheet. London: British Heart Foundation; 2006."},{"key":"key20211019135901851_ref1-bib660","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1136\/hrt.80.1.40","article-title":"Coronary event and case fatality rates in an English population: results of the Oxford myocardial infarction incidence study. The Oxford Myocardial Infarction Incidence Study Group","volume":"80","author":"Volmink","year":"1998","journal-title":"Heart"},{"key":"key20211019135901851_ref1-bib661","unstructured":"ONS. Health Statistics Quarterly, No. 12. London: The Stationery Office; 2001."},{"key":"key20211019135901851_ref1-bib662","unstructured":"Asthma UK. Where Do We Stand?: Asthma in the UK Today. London: Asthma UK; 2004."},{"key":"key20211019135901851_ref1-bib663","unstructured":"Health Pricing Office (HPO). Hospital Inpatient Enquiry (HIPE) database. Dublin: Health Service Executive (HSE), 2016."},{"key":"key20211019135901851_ref1-bib664","unstructured":"Primary Care Reimbursement Service (PCRS). Statistical Analysis of Claims and Payments 2014. Dublin: 2014."}],"container-title":["Health Technology Assessment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2037821","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/publications\/hta25590\/hta25590.xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2037821","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T06:53:29Z","timestamp":1699685609000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/hta\/hta25590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":664,"journal-issue":{"issue":"59","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["10.3310\/hta25590"],"URL":"https:\/\/doi.org\/10.3310\/hta25590","relation":{},"ISSN":["1366-5278","2046-4924"],"issn-type":[{"value":"1366-5278","type":"print"},{"value":"2046-4924","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"This content has been made freely available to all.","name":"free","label":"Free to read"},{"value":"9-2016","name":"contractual_start_date","label":"Contractual start date","group":{"name":"article_history","label":"Article History"}},{"value":"10-2019","name":"editorial_review_begun","label":"Editorial review begun","group":{"name":"article_history","label":"Article History"}},{"value":"6-2020","name":"accepted_for_publication","label":"Accepted for publication","group":{"name":"article_history","label":"Article History"}}]}}